Gene: JAK1
Ensembl ID : ENSG00000162434
Description: Janus kinase 1
Gene Synonyms: JAK1A,JAK1B,JTK3
19 APIs:
238 Possible Orthologues:

Disease R-HSA-1643685
Interferon gamma signaling R-HSA-877300
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-21 signaling R-HSA-9020958
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-2 signaling R-HSA-9020558
Interleukin-9 signaling R-HSA-8985947
SARS-CoV Infections R-HSA-9679506
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Regulation of IFNA/IFNB signaling R-HSA-912694
Other interleukin signaling R-HSA-449836
Immune System R-HSA-168256
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
MAPK1/MAPK3 signaling R-HSA-5684996
Interleukin-2 family signaling R-HSA-451927
Interleukin-12 signaling R-HSA-9020591
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin-35 Signalling R-HSA-8984722
MAPK3 (ERK1) activation R-HSA-110056
Signal Transduction R-HSA-162582
Interleukin-27 signaling R-HSA-9020956
Interleukin-7 signaling R-HSA-1266695
Interleukin-10 signaling R-HSA-6783783
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
MAPK family signaling cascades R-HSA-5683057
Infectious disease R-HSA-5663205
Interleukin-6 signaling R-HSA-1059683
RAF/MAP kinase cascade R-HSA-5673001
Interleukin-15 signaling R-HSA-8983432
Regulation of IFNG signaling R-HSA-877312
Interleukin receptor SHC signaling R-HSA-912526
Potential therapeutics for SARS R-HSA-9679191
SARS-CoV-2 Infection R-HSA-9694516
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
SARS-CoV-2-host interactions R-HSA-9705683
Interferon Signaling R-HSA-913531
Interferon alpha/beta signaling R-HSA-909733
Signaling by Interleukins R-HSA-449147
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Interleukin-12 family signaling R-HSA-447115
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Interleukin-6 family signaling R-HSA-6783589
MAPK1 (ERK2) activation R-HSA-112411
Interleukin-20 family signaling R-HSA-8854691
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interleukin-12 signaling R-HSA-9020591
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Regulation of IFNG signaling R-HSA-877312
Interferon gamma signaling R-HSA-877300
Disease R-HSA-1643685
Interleukin-7 signaling R-HSA-1266695
MAPK1/MAPK3 signaling R-HSA-5684996
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
MAPK1 (ERK2) activation R-HSA-112411
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Other interleukin signaling R-HSA-449836
Immune System R-HSA-168256
ISG15 antiviral mechanism R-HSA-1169408
MAPK family signaling cascades R-HSA-5683057
SARS-CoV-2 Infection R-HSA-9694516
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-2 family signaling R-HSA-451927
Interleukin-6 signaling R-HSA-1059683
RAF-independent MAPK1/3 activation R-HSA-112409
SARS-CoV-2-host interactions R-HSA-9705683
Signaling by Interleukins R-HSA-449147
Interleukin-21 signaling R-HSA-9020958
Interleukin-12 family signaling R-HSA-447115
Interferon Signaling R-HSA-913531
Interleukin-35 Signalling R-HSA-8984722
Interleukin-6 family signaling R-HSA-6783589
Interleukin-27 signaling R-HSA-9020956
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
SARS-CoV Infections R-HSA-9679506
Interleukin-9 signaling R-HSA-8985947
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Interleukin-2 signaling R-HSA-9020558
MAPK3 (ERK1) activation R-HSA-110056
Regulation of IFNA/IFNB signaling R-HSA-912694
Interleukin receptor SHC signaling R-HSA-912526
Signal Transduction R-HSA-162582
RAF/MAP kinase cascade R-HSA-5673001
Interleukin-15 signaling R-HSA-8983432
Interleukin-10 signaling R-HSA-6783783
Infectious disease R-HSA-5663205
Potential therapeutics for SARS R-HSA-9679191
Interleukin-20 family signaling R-HSA-8854691
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interferon alpha/beta signaling R-HSA-909733
Interferon gamma signaling R-HSA-877300
Interleukin-10 signaling R-HSA-6783783
MAPK1/MAPK3 signaling R-HSA-5684996
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Potential therapeutics for SARS R-HSA-9679191
MAPK3 (ERK1) activation R-HSA-110056
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Interferon Signaling R-HSA-913531
Interleukin-35 Signalling R-HSA-8984722
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Signal Transduction R-HSA-162582
Regulation of IFNA/IFNB signaling R-HSA-912694
ISG15 antiviral mechanism R-HSA-1169408
Infectious disease R-HSA-5663205
SARS-CoV-2 Infection R-HSA-9694516
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
SARS-CoV-2-host interactions R-HSA-9705683
Interleukin-15 signaling R-HSA-8983432
Interferon alpha/beta signaling R-HSA-909733
RAF/MAP kinase cascade R-HSA-5673001
Interleukin-7 signaling R-HSA-1266695
Signaling by Interleukins R-HSA-449147
Interleukin-12 signaling R-HSA-9020591
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signaling by CSF3 (G-CSF) R-HSA-9674555
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin-6 family signaling R-HSA-6783589
Interleukin-9 signaling R-HSA-8985947
Immune System R-HSA-168256
Interleukin-21 signaling R-HSA-9020958
Disease R-HSA-1643685
Interleukin-6 signaling R-HSA-1059683
Regulation of IFNG signaling R-HSA-877312
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
SARS-CoV Infections R-HSA-9679506
MAPK family signaling cascades R-HSA-5683057
Interleukin-20 family signaling R-HSA-8854691
Interleukin-12 family signaling R-HSA-447115
Interleukin-2 signaling R-HSA-9020558
Interleukin receptor SHC signaling R-HSA-912526
Interleukin-27 signaling R-HSA-9020956
Interleukin-2 family signaling R-HSA-451927
MAPK1 (ERK2) activation R-HSA-112411
Other interleukin signaling R-HSA-449836
Interleukin-35 Signalling R-HSA-8984722
Signaling by CSF3 (G-CSF) R-HSA-9674555
Immune System R-HSA-168256
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
ISG15 antiviral mechanism R-HSA-1169408
RAF/MAP kinase cascade R-HSA-5673001
Interleukin-20 family signaling R-HSA-8854691
MAPK1 (ERK2) activation R-HSA-112411
Interleukin-15 signaling R-HSA-8983432
Interleukin-6 family signaling R-HSA-6783589
Potential therapeutics for SARS R-HSA-9679191
Interleukin-21 signaling R-HSA-9020958
Regulation of IFNA/IFNB signaling R-HSA-912694
Infectious disease R-HSA-5663205
RAF-independent MAPK1/3 activation R-HSA-112409
SARS-CoV Infections R-HSA-9679506
Interleukin-27 signaling R-HSA-9020956
Interleukin-12 family signaling R-HSA-447115
Interleukin-6 signaling R-HSA-1059683
Signal Transduction R-HSA-162582
Interleukin-2 signaling R-HSA-9020558
Interferon alpha/beta signaling R-HSA-909733
Interleukin-10 signaling R-HSA-6783783
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Regulation of IFNG signaling R-HSA-877312
MAPK1/MAPK3 signaling R-HSA-5684996
Cytokine Signaling in Immune system R-HSA-1280215
SARS-CoV-2-host interactions R-HSA-9705683
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Disease R-HSA-1643685
SARS-CoV-2 Infection R-HSA-9694516
Interleukin-7 signaling R-HSA-1266695
MAPK family signaling cascades R-HSA-5683057
Signaling by Interleukins R-HSA-449147
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Interleukin-12 signaling R-HSA-9020591
Interleukin receptor SHC signaling R-HSA-912526
Other interleukin signaling R-HSA-449836
Interleukin-9 signaling R-HSA-8985947
MAPK3 (ERK1) activation R-HSA-110056
Interleukin-2 family signaling R-HSA-451927
Interferon Signaling R-HSA-913531
Interferon gamma signaling R-HSA-877300
Interleukin-15 signaling R-HSA-8983432
Infectious disease R-HSA-5663205
Interleukin-7 signaling R-HSA-1266695
SARS-CoV-2 Infection R-HSA-9694516
Interleukin-6 signaling R-HSA-1059683
RAF/MAP kinase cascade R-HSA-5673001
Interferon gamma signaling R-HSA-877300
Interleukin-12 family signaling R-HSA-447115
Regulation of IFNG signaling R-HSA-877312
SARS-CoV-2-host interactions R-HSA-9705683
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Interferon Signaling R-HSA-913531
Interleukin-2 signaling R-HSA-9020558
Regulation of IFNA/IFNB signaling R-HSA-912694
Other interleukin signaling R-HSA-449836
Interleukin-21 signaling R-HSA-9020958
Signaling by Interleukins R-HSA-449147
Disease R-HSA-1643685
Interleukin-10 signaling R-HSA-6783783
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Interleukin-20 family signaling R-HSA-8854691
Interleukin-6 family signaling R-HSA-6783589
SARS-CoV Infections R-HSA-9679506
Immune System R-HSA-168256
Interleukin-9 signaling R-HSA-8985947
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin receptor SHC signaling R-HSA-912526
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interleukin-27 signaling R-HSA-9020956
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Interleukin-12 signaling R-HSA-9020591
MAPK3 (ERK1) activation R-HSA-110056
Potential therapeutics for SARS R-HSA-9679191
Interleukin-2 family signaling R-HSA-451927
Interleukin-35 Signalling R-HSA-8984722
Signal Transduction R-HSA-162582
MAPK1 (ERK2) activation R-HSA-112411
MAPK family signaling cascades R-HSA-5683057
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
ISG15 antiviral mechanism R-HSA-1169408
Interferon alpha/beta signaling R-HSA-909733
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interferon alpha/beta signaling R-HSA-909733
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Regulation of IFNG signaling R-HSA-877312
Immune System R-HSA-168256
Regulation of IFNA/IFNB signaling R-HSA-912694
Interferon gamma signaling R-HSA-877300
Disease R-HSA-1643685
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin-2 family signaling R-HSA-451927
Signal Transduction R-HSA-162582
MAPK1 (ERK2) activation R-HSA-112411
Interferon Signaling R-HSA-913531
SARS-CoV-2 Infection R-HSA-9694516
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-6 signaling R-HSA-1059683
MAPK3 (ERK1) activation R-HSA-110056
Interleukin-10 signaling R-HSA-6783783
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Interleukin-15 signaling R-HSA-8983432
Interleukin-35 Signalling R-HSA-8984722
Interleukin-12 signaling R-HSA-9020591
MAPK family signaling cascades R-HSA-5683057
Interleukin-6 family signaling R-HSA-6783589
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-12 family signaling R-HSA-447115
SARS-CoV Infections R-HSA-9679506
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Interleukin-21 signaling R-HSA-9020958
Interleukin-9 signaling R-HSA-8985947
SARS-CoV-2-host interactions R-HSA-9705683
MAPK1/MAPK3 signaling R-HSA-5684996
Interleukin-20 family signaling R-HSA-8854691
Interleukin receptor SHC signaling R-HSA-912526
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Potential therapeutics for SARS R-HSA-9679191
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Signaling by Interleukins R-HSA-449147
RAF/MAP kinase cascade R-HSA-5673001
Infectious disease R-HSA-5663205
Other interleukin signaling R-HSA-449836
Interleukin-27 signaling R-HSA-9020956
Interleukin-2 signaling R-HSA-9020558
Interleukin-7 signaling R-HSA-1266695
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Interleukin-20 family signaling R-HSA-8854691
Signaling by CSF3 (G-CSF) R-HSA-9674555
SARS-CoV-2 Infection R-HSA-9694516
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Interferon alpha/beta signaling R-HSA-909733
MAPK family signaling cascades R-HSA-5683057
Interleukin-2 family signaling R-HSA-451927
SARS-CoV-2-host interactions R-HSA-9705683
Signal Transduction R-HSA-162582
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-7 signaling R-HSA-1266695
Interleukin-10 signaling R-HSA-6783783
Interleukin-21 signaling R-HSA-9020958
Interleukin receptor SHC signaling R-HSA-912526
MAPK1/MAPK3 signaling R-HSA-5684996
Disease R-HSA-1643685
Regulation of IFNG signaling R-HSA-877312
Interleukin-15 signaling R-HSA-8983432
Other interleukin signaling R-HSA-449836
Signaling by Interleukins R-HSA-449147
Interleukin-2 signaling R-HSA-9020558
Interferon Signaling R-HSA-913531
MAPK3 (ERK1) activation R-HSA-110056
SARS-CoV Infections R-HSA-9679506
Interleukin-9 signaling R-HSA-8985947
Interleukin-12 signaling R-HSA-9020591
Interferon gamma signaling R-HSA-877300
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Interleukin-6 family signaling R-HSA-6783589
Infectious disease R-HSA-5663205
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Interleukin-35 Signalling R-HSA-8984722
Immune System R-HSA-168256
Regulation of IFNA/IFNB signaling R-HSA-912694
MAPK1 (ERK2) activation R-HSA-112411
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
RAF/MAP kinase cascade R-HSA-5673001
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin-6 signaling R-HSA-1059683
Potential therapeutics for SARS R-HSA-9679191
Interleukin-12 family signaling R-HSA-447115
Interleukin-27 signaling R-HSA-9020956
Cytokine Signaling in Immune system R-HSA-1280215
Cytokine Signaling in Immune system R-HSA-1280215
Interleukin-21 signaling R-HSA-9020958
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
Interleukin-2 family signaling R-HSA-451927
Interleukin-7 signaling R-HSA-1266695
Signaling by CSF3 (G-CSF) R-HSA-9674555
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Interleukin-35 Signalling R-HSA-8984722
MAPK1/MAPK3 signaling R-HSA-5684996
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Immune System R-HSA-168256
Interleukin-20 family signaling R-HSA-8854691
Regulation of IFNG signaling R-HSA-877312
SARS-CoV-2 Infection R-HSA-9694516
MAPK3 (ERK1) activation R-HSA-110056
RAF-independent MAPK1/3 activation R-HSA-112409
Interleukin-9 signaling R-HSA-8985947
Other interleukin signaling R-HSA-449836
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Interleukin-6 family signaling R-HSA-6783589
MAPK family signaling cascades R-HSA-5683057
MAPK1 (ERK2) activation R-HSA-112411
Interleukin receptor SHC signaling R-HSA-912526
Signaling by Interleukins R-HSA-449147
Signal Transduction R-HSA-162582
SARS-CoV Infections R-HSA-9679506
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-12 family signaling R-HSA-447115
Disease R-HSA-1643685
Interferon gamma signaling R-HSA-877300
Infectious disease R-HSA-5663205
Interferon Signaling R-HSA-913531
Interleukin-12 signaling R-HSA-9020591
Potential therapeutics for SARS R-HSA-9679191
Interleukin-27 signaling R-HSA-9020956
Regulation of IFNA/IFNB signaling R-HSA-912694
Interferon alpha/beta signaling R-HSA-909733
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Interleukin-10 signaling R-HSA-6783783
RAF/MAP kinase cascade R-HSA-5673001
Interleukin-6 signaling R-HSA-1059683
Interleukin-2 signaling R-HSA-9020558
SARS-CoV-2-host interactions R-HSA-9705683
Interleukin-15 signaling R-HSA-8983432
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-7 signaling R-HSA-1266695
Immune System R-HSA-168256
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
RAF/MAP kinase cascade R-HSA-5673001
MAPK1/MAPK3 signaling R-HSA-5684996
SARS-CoV-2-host interactions R-HSA-9705683
Potential therapeutics for SARS R-HSA-9679191
Interleukin-27 signaling R-HSA-9020956
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Interleukin-20 family signaling R-HSA-8854691
Interleukin-15 signaling R-HSA-8983432
Interleukin-2 family signaling R-HSA-451927
Interleukin-10 signaling R-HSA-6783783
SARS-CoV Infections R-HSA-9679506
Interleukin-2 signaling R-HSA-9020558
Interleukin-35 Signalling R-HSA-8984722
Regulation of IFNG signaling R-HSA-877312
Signal Transduction R-HSA-162582
Interleukin-21 signaling R-HSA-9020958
Disease R-HSA-1643685
Interleukin-6 family signaling R-HSA-6783589
Interferon Signaling R-HSA-913531
RAF-independent MAPK1/3 activation R-HSA-112409
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
MAPK1 (ERK2) activation R-HSA-112411
Cytokine Signaling in Immune system R-HSA-1280215
Regulation of IFNA/IFNB signaling R-HSA-912694
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
SARS-CoV-2 Infection R-HSA-9694516
Interleukin-6 signaling R-HSA-1059683
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
MAPK family signaling cascades R-HSA-5683057
Interferon alpha/beta signaling R-HSA-909733
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interleukin receptor SHC signaling R-HSA-912526
Infectious disease R-HSA-5663205
Interleukin-12 signaling R-HSA-9020591
MAPK3 (ERK1) activation R-HSA-110056
Interleukin-12 family signaling R-HSA-447115
Interleukin-9 signaling R-HSA-8985947
Signaling by Interleukins R-HSA-449147
Other interleukin signaling R-HSA-449836
Interferon gamma signaling R-HSA-877300
Infectious disease R-HSA-5663205
Interleukin-9 signaling R-HSA-8985947
Interferon Signaling R-HSA-913531
Disease R-HSA-1643685
Interleukin-6 signaling R-HSA-1059683
MAPK1 (ERK2) activation R-HSA-112411
RAF-independent MAPK1/3 activation R-HSA-112409
Other interleukin signaling R-HSA-449836
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
RAF/MAP kinase cascade R-HSA-5673001
Signaling by CSF3 (G-CSF) R-HSA-9674555
Interleukin-12 family signaling R-HSA-447115
MAPK family signaling cascades R-HSA-5683057
Immune System R-HSA-168256
Interleukin receptor SHC signaling R-HSA-912526
SARS-CoV-2-host interactions R-HSA-9705683
Regulation of IFNG signaling R-HSA-877312
Interleukin-2 family signaling R-HSA-451927
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Regulation of IFNA/IFNB signaling R-HSA-912694
Interleukin-10 signaling R-HSA-6783783
MAPK1/MAPK3 signaling R-HSA-5684996
Interferon gamma signaling R-HSA-877300
Interleukin-20 family signaling R-HSA-8854691
Signaling by Interleukins R-HSA-449147
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Interleukin-27 signaling R-HSA-9020956
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410
Interferon alpha/beta signaling R-HSA-909733
Interleukin-15 signaling R-HSA-8983432
Interleukin-2 signaling R-HSA-9020558
Interleukin-21 signaling R-HSA-9020958
MAPK3 (ERK1) activation R-HSA-110056
Cytokine Signaling in Immune system R-HSA-1280215
IL-6-type cytokine receptor ligand interactions R-HSA-6788467
ISG15 antiviral mechanism R-HSA-1169408
Interleukin-7 signaling R-HSA-1266695
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
SARS-CoV Infections R-HSA-9679506
Interleukin-35 Signalling R-HSA-8984722
Potential therapeutics for SARS R-HSA-9679191
SARS-CoV-2 Infection R-HSA-9694516
Signal Transduction R-HSA-162582
Interleukin-6 family signaling R-HSA-6783589
Interleukin-12 signaling R-HSA-9020591

Expression Atlas ENSG00000162434
LRG display in Ensembl gene LRG_1398
NCBI gene (formerly Entrezgene) 3716
GeneCards 6190
HGNC Symbol HGNC:6190
MIM gene 147795
MIM morbid 618999
UniProtKB Gene Name P23458
WikiGene 3716
Gene: PRKCB
Ensembl ID : ENSG00000166501
Description: protein kinase C beta
Gene Synonyms: PKCB,PRKCB1,PRKCB2
7 APIs:
299 Possible Orthologues:

Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Neuronal System R-HSA-112316
Transcriptional regulation by RUNX1 R-HSA-8878171
Cell Cycle R-HSA-1640170
Trafficking of AMPA receptors R-HSA-399719
Signaling by VEGF R-HSA-194138
WNT5A-dependent internalization of FZD4 R-HSA-5099900
G alpha (z) signalling events R-HSA-418597
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Immune System R-HSA-168256
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
VEGFR2 mediated cell proliferation R-HSA-5218921
Adaptive Immune System R-HSA-1280218
Disinhibition of SNARE formation R-HSA-114516
Signaling by GPCR R-HSA-372790
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Beta-catenin independent WNT signaling R-HSA-3858494
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Generic Transcription Pathway R-HSA-212436
M Phase R-HSA-68886
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Hemostasis R-HSA-109582
Nuclear Envelope Breakdown R-HSA-2980766
Gene expression (Transcription) R-HSA-74160
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
GPCR downstream signalling R-HSA-388396
Signaling by WNT R-HSA-195721
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Mitotic Prophase R-HSA-68875
RHO GTPase Effectors R-HSA-195258
Platelet activation, signaling and aggregation R-HSA-76002
PCP/CE pathway R-HSA-4086400
Transmission across Chemical Synapses R-HSA-112315
RNA Polymerase II Transcription R-HSA-73857
Signaling by Rho GTPases R-HSA-194315
Signal Transduction R-HSA-162582
VEGFA-VEGFR2 Pathway R-HSA-4420097
Activation of NF-kappaB in B cells R-HSA-1169091
Cell Cycle, Mitotic R-HSA-69278
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Transmission across Chemical Synapses R-HSA-112315
Beta-catenin independent WNT signaling R-HSA-3858494
Gene expression (Transcription) R-HSA-74160
Signal Transduction R-HSA-162582
G alpha (z) signalling events R-HSA-418597
VEGFR2 mediated cell proliferation R-HSA-5218921
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
VEGFA-VEGFR2 Pathway R-HSA-4420097
Trafficking of AMPA receptors R-HSA-399719
Neuronal System R-HSA-112316
Cell Cycle R-HSA-1640170
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Disinhibition of SNARE formation R-HSA-114516
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Transcriptional regulation by RUNX1 R-HSA-8878171
Nuclear Envelope Breakdown R-HSA-2980766
M Phase R-HSA-68886
Immune System R-HSA-168256
Hemostasis R-HSA-109582
Signaling by GPCR R-HSA-372790
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Platelet activation, signaling and aggregation R-HSA-76002
Signaling by WNT R-HSA-195721
Cell Cycle, Mitotic R-HSA-69278
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Generic Transcription Pathway R-HSA-212436
Mitotic Prophase R-HSA-68875
Signaling by the B Cell Receptor (BCR) R-HSA-983705
RNA Polymerase II Transcription R-HSA-73857
Depolymerisation of the Nuclear Lamina R-HSA-4419969
PCP/CE pathway R-HSA-4086400
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
GPCR downstream signalling R-HSA-388396
Signaling by VEGF R-HSA-194138
Activation of NF-kappaB in B cells R-HSA-1169091
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Signaling by Rho GTPases R-HSA-194315
Adaptive Immune System R-HSA-1280218
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
RHO GTPase Effectors R-HSA-195258
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
G alpha (z) signalling events R-HSA-418597
GPCR downstream signalling R-HSA-388396
Nuclear Envelope Breakdown R-HSA-2980766
Platelet activation, signaling and aggregation R-HSA-76002
Transcriptional regulation by RUNX1 R-HSA-8878171
Activation of NF-kappaB in B cells R-HSA-1169091
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Trafficking of AMPA receptors R-HSA-399719
Signaling by Rho GTPases R-HSA-194315
Cell Cycle, Mitotic R-HSA-69278
RHO GTPase Effectors R-HSA-195258
Hemostasis R-HSA-109582
Cell Cycle R-HSA-1640170
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
VEGFA-VEGFR2 Pathway R-HSA-4420097
M Phase R-HSA-68886
Signal Transduction R-HSA-162582
Immune System R-HSA-168256
Signaling by GPCR R-HSA-372790
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Transmission across Chemical Synapses R-HSA-112315
Neuronal System R-HSA-112316
Gene expression (Transcription) R-HSA-74160
Generic Transcription Pathway R-HSA-212436
Signaling by WNT R-HSA-195721
Signaling by VEGF R-HSA-194138
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Adaptive Immune System R-HSA-1280218
Beta-catenin independent WNT signaling R-HSA-3858494
VEGFR2 mediated cell proliferation R-HSA-5218921
Mitotic Prophase R-HSA-68875
RNA Polymerase II Transcription R-HSA-73857
Disinhibition of SNARE formation R-HSA-114516
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
PCP/CE pathway R-HSA-4086400
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Adaptive Immune System R-HSA-1280218
M Phase R-HSA-68886
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by Rho GTPases R-HSA-194315
Signaling by VEGF R-HSA-194138
Immune System R-HSA-168256
Nuclear Envelope Breakdown R-HSA-2980766
G alpha (z) signalling events R-HSA-418597
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Neuronal System R-HSA-112316
Generic Transcription Pathway R-HSA-212436
WNT5A-dependent internalization of FZD4 R-HSA-5099900
VEGFA-VEGFR2 Pathway R-HSA-4420097
Transcriptional regulation by RUNX1 R-HSA-8878171
Signaling by GPCR R-HSA-372790
Cell Cycle R-HSA-1640170
Mitotic Prophase R-HSA-68875
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
GPCR downstream signalling R-HSA-388396
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Cell Cycle, Mitotic R-HSA-69278
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Platelet activation, signaling and aggregation R-HSA-76002
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Gene expression (Transcription) R-HSA-74160
Trafficking of AMPA receptors R-HSA-399719
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Signaling by WNT R-HSA-195721
Signal Transduction R-HSA-162582
Activation of NF-kappaB in B cells R-HSA-1169091
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Hemostasis R-HSA-109582
Beta-catenin independent WNT signaling R-HSA-3858494
Transmission across Chemical Synapses R-HSA-112315
RNA Polymerase II Transcription R-HSA-73857
RHO GTPase Effectors R-HSA-195258
PCP/CE pathway R-HSA-4086400
VEGFR2 mediated cell proliferation R-HSA-5218921
Disinhibition of SNARE formation R-HSA-114516
Depolymerisation of the Nuclear Lamina R-HSA-4419969
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Mitotic Prophase R-HSA-68875
Trafficking of AMPA receptors R-HSA-399719
Disinhibition of SNARE formation R-HSA-114516
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Signal Transduction R-HSA-162582
Generic Transcription Pathway R-HSA-212436
Signaling by Rho GTPases R-HSA-194315
Adaptive Immune System R-HSA-1280218
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Transmission across Chemical Synapses R-HSA-112315
Cell Cycle, Mitotic R-HSA-69278
Activation of NF-kappaB in B cells R-HSA-1169091
RHO GTPase Effectors R-HSA-195258
Cell Cycle R-HSA-1640170
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Transcriptional regulation by RUNX1 R-HSA-8878171
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Neuronal System R-HSA-112316
Beta-catenin independent WNT signaling R-HSA-3858494
Platelet activation, signaling and aggregation R-HSA-76002
Signaling by the B Cell Receptor (BCR) R-HSA-983705
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Gene expression (Transcription) R-HSA-74160
VEGFR2 mediated cell proliferation R-HSA-5218921
Signaling by VEGF R-HSA-194138
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
PCP/CE pathway R-HSA-4086400
G alpha (z) signalling events R-HSA-418597
Signaling by WNT R-HSA-195721
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
GPCR downstream signalling R-HSA-388396
RNA Polymerase II Transcription R-HSA-73857
Immune System R-HSA-168256
Hemostasis R-HSA-109582
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
M Phase R-HSA-68886
VEGFA-VEGFR2 Pathway R-HSA-4420097
Signaling by GPCR R-HSA-372790
Nuclear Envelope Breakdown R-HSA-2980766
Platelet activation, signaling and aggregation R-HSA-76002
Disinhibition of SNARE formation R-HSA-114516
Activation of NF-kappaB in B cells R-HSA-1169091
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Trafficking of AMPA receptors R-HSA-399719
Generic Transcription Pathway R-HSA-212436
WNT5A-dependent internalization of FZD4 R-HSA-5099900
RNA Polymerase II Transcription R-HSA-73857
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
VEGFA-VEGFR2 Pathway R-HSA-4420097
Signaling by the B Cell Receptor (BCR) R-HSA-983705
VEGFR2 mediated cell proliferation R-HSA-5218921
Transmission across Chemical Synapses R-HSA-112315
G alpha (z) signalling events R-HSA-418597
Gene expression (Transcription) R-HSA-74160
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Cell Cycle R-HSA-1640170
PCP/CE pathway R-HSA-4086400
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Cell Cycle, Mitotic R-HSA-69278
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Mitotic Prophase R-HSA-68875
Signaling by Rho GTPases R-HSA-194315
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
M Phase R-HSA-68886
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Hemostasis R-HSA-109582
Neuronal System R-HSA-112316
Beta-catenin independent WNT signaling R-HSA-3858494
Nuclear Envelope Breakdown R-HSA-2980766
RHO GTPase Effectors R-HSA-195258
Signaling by WNT R-HSA-195721
Signaling by VEGF R-HSA-194138
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Transcriptional regulation by RUNX1 R-HSA-8878171
GPCR downstream signalling R-HSA-388396
Adaptive Immune System R-HSA-1280218
Signaling by GPCR R-HSA-372790
Signal Transduction R-HSA-162582
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Nuclear Envelope Breakdown R-HSA-2980766
Mitotic Prophase R-HSA-68875
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Signaling by WNT R-HSA-195721
VEGFR2 mediated cell proliferation R-HSA-5218921
Signaling by VEGF R-HSA-194138
Platelet activation, signaling and aggregation R-HSA-76002
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Beta-catenin independent WNT signaling R-HSA-3858494
GPCR downstream signalling R-HSA-388396
Trafficking of AMPA receptors R-HSA-399719
Adaptive Immune System R-HSA-1280218
Transcriptional regulation by RUNX1 R-HSA-8878171
Activation of NF-kappaB in B cells R-HSA-1169091
Signaling by Rho GTPases R-HSA-194315
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Neuronal System R-HSA-112316
Signaling by GPCR R-HSA-372790
PCP/CE pathway R-HSA-4086400
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
M Phase R-HSA-68886
Generic Transcription Pathway R-HSA-212436
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
G alpha (z) signalling events R-HSA-418597
WNT5A-dependent internalization of FZD4 R-HSA-5099900
VEGFA-VEGFR2 Pathway R-HSA-4420097
Gene expression (Transcription) R-HSA-74160
Signal Transduction R-HSA-162582
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Immune System R-HSA-168256
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Transmission across Chemical Synapses R-HSA-112315
Hemostasis R-HSA-109582
RHO GTPase Effectors R-HSA-195258
Depolymerisation of the Nuclear Lamina R-HSA-4419969
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Cell Cycle R-HSA-1640170
Disinhibition of SNARE formation R-HSA-114516
Cell Cycle, Mitotic R-HSA-69278
RNA Polymerase II Transcription R-HSA-73857
M Phase R-HSA-68886
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Cell Cycle, Mitotic R-HSA-69278
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
RNA Polymerase II Transcription R-HSA-73857
GPCR downstream signalling R-HSA-388396
Platelet activation, signaling and aggregation R-HSA-76002
Immune System R-HSA-168256
Cell Cycle R-HSA-1640170
Signaling by Rho GTPases R-HSA-194315
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Neuronal System R-HSA-112316
Signaling by VEGF R-HSA-194138
RHO GTPase Effectors R-HSA-195258
Generic Transcription Pathway R-HSA-212436
Hemostasis R-HSA-109582
Signaling by WNT R-HSA-195721
Nuclear Envelope Breakdown R-HSA-2980766
VEGFR2 mediated cell proliferation R-HSA-5218921
G alpha (z) signalling events R-HSA-418597
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Signal Transduction R-HSA-162582
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Transmission across Chemical Synapses R-HSA-112315
Disinhibition of SNARE formation R-HSA-114516
Activation of NF-kappaB in B cells R-HSA-1169091
PCP/CE pathway R-HSA-4086400
Signaling by GPCR R-HSA-372790
Mitotic Prophase R-HSA-68875
VEGFA-VEGFR2 Pathway R-HSA-4420097
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Adaptive Immune System R-HSA-1280218
Transcriptional regulation by RUNX1 R-HSA-8878171
Gene expression (Transcription) R-HSA-74160
Beta-catenin independent WNT signaling R-HSA-3858494
Trafficking of AMPA receptors R-HSA-399719
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Signaling by GPCR R-HSA-372790
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Transcriptional regulation by RUNX1 R-HSA-8878171
Trafficking of AMPA receptors R-HSA-399719
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Nuclear Envelope Breakdown R-HSA-2980766
Disinhibition of SNARE formation R-HSA-114516
VEGFA-VEGFR2 Pathway R-HSA-4420097
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Transmission across Chemical Synapses R-HSA-112315
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Immune System R-HSA-168256
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Platelet activation, signaling and aggregation R-HSA-76002
Adaptive Immune System R-HSA-1280218
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
Gene expression (Transcription) R-HSA-74160
GPCR downstream signalling R-HSA-388396
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
M Phase R-HSA-68886
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Cell Cycle, Mitotic R-HSA-69278
PCP/CE pathway R-HSA-4086400
Signaling by Rho GTPases R-HSA-194315
RHO GTPase Effectors R-HSA-195258
Signal Transduction R-HSA-162582
Beta-catenin independent WNT signaling R-HSA-3858494
RNA Polymerase II Transcription R-HSA-73857
Neuronal System R-HSA-112316
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Signaling by WNT R-HSA-195721
Cell Cycle R-HSA-1640170
Signaling by VEGF R-HSA-194138
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Hemostasis R-HSA-109582
Mitotic Prophase R-HSA-68875
Activation of NF-kappaB in B cells R-HSA-1169091
Generic Transcription Pathway R-HSA-212436
G alpha (z) signalling events R-HSA-418597
VEGFR2 mediated cell proliferation R-HSA-5218921
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Cell Cycle R-HSA-1640170
Disinhibition of SNARE formation R-HSA-114516
Neuronal System R-HSA-112316
RHO GTPases Activate NADPH Oxidases R-HSA-5668599
M Phase R-HSA-68886
RHO GTPase Effectors R-HSA-195258
Signaling by the B Cell Receptor (BCR) R-HSA-983705
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Activation of NF-kappaB in B cells R-HSA-1169091
Adaptive Immune System R-HSA-1280218
Cell Cycle, Mitotic R-HSA-69278
Signaling by WNT R-HSA-195721
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246
G alpha (z) signalling events R-HSA-418597
VEGFR2 mediated cell proliferation R-HSA-5218921
Transcriptional regulation by RUNX1 R-HSA-8878171
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372
Signaling by Rho GTPases R-HSA-194315
Depolymerisation of the Nuclear Lamina R-HSA-4419969
Signaling by VEGF R-HSA-194138
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Transmission across Chemical Synapses R-HSA-112315
Signal Transduction R-HSA-162582
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Signaling by GPCR R-HSA-372790
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Nuclear Envelope Breakdown R-HSA-2980766
Immune System R-HSA-168256
Gene expression (Transcription) R-HSA-74160
Hemostasis R-HSA-109582
Mitotic Prophase R-HSA-68875
Beta-catenin independent WNT signaling R-HSA-3858494
PCP/CE pathway R-HSA-4086400
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
GPCR downstream signalling R-HSA-388396
VEGFA-VEGFR2 Pathway R-HSA-4420097
RNA Polymerase II Transcription R-HSA-73857
Platelet activation, signaling and aggregation R-HSA-76002
Trafficking of AMPA receptors R-HSA-399719
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Generic Transcription Pathway R-HSA-212436

Expression Atlas ENSG00000166501
NCBI gene (formerly Entrezgene) 5579
GeneCards 9395
HGNC Symbol HGNC:9395
MIM gene 176970
UniProtKB Gene Name P05771
WikiGene 5579
Gene: AKT3
Ensembl ID : ENSG00000117020
Description: AKT serine/threonine kinase 3
Gene Synonyms: PKBG,PRKBG,RAC-GAMMA
14 APIs:
201 Possible Orthologues:

Intrinsic Pathway for Apoptosis R-HSA-109606
Cellular response to chemical stress R-HSA-9711123
Transcriptional Regulation by TP53 R-HSA-3700989
S Phase R-HSA-69242
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
Apoptosis R-HSA-109581
Vesicle-mediated transport R-HSA-5653656
GPCR downstream signalling R-HSA-388396
Signaling by VEGF R-HSA-194138
Gene expression (Transcription) R-HSA-74160
TP53 Regulates Metabolic Genes R-HSA-5628897
Cellular responses to stress R-HSA-2262752
AKT-mediated inactivation of FOXO1A R-HSA-211163
Costimulation by the CD28 family R-HSA-388841
CD28 dependent PI3K/Akt signaling R-HSA-389357
Signaling by GPCR R-HSA-372790
Downregulation of ERBB2 signaling R-HSA-8863795
PIP3 activates AKT signaling R-HSA-1257604
AKT phosphorylates targets in the cytosol R-HSA-198323
Regulation of beta-cell development R-HSA-186712
Regulation of TP53 Expression and Degradation R-HSA-6806003
G-protein beta:gamma signalling R-HSA-397795
Transcriptional regulation by RUNX2 R-HSA-8878166
Rab regulation of trafficking R-HSA-9007101
Generic Transcription Pathway R-HSA-212436
SARS-CoV-2 Infection R-HSA-9694516
Cytokine Signaling in Immune system R-HSA-1280215
RUNX2 regulates genes involved in cell migration R-HSA-8941332
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
PTEN Regulation R-HSA-6807070
Disease R-HSA-1643685
SARS-CoV Infections R-HSA-9679506
Membrane Trafficking R-HSA-199991
Regulation of PTEN stability and activity R-HSA-8948751
Mitotic G1 phase and G1/S transition R-HSA-453279
Regulation of TP53 Activity R-HSA-5633007
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
G1/S Transition R-HSA-69206
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
CD28 co-stimulation R-HSA-389356
Signal Transduction R-HSA-162582
ESR-mediated signaling R-HSA-8939211
Signaling by Nuclear Receptors R-HSA-9006931
Negative regulation of the PI3K/AKT network R-HSA-199418
FLT3 Signaling R-HSA-9607240
SARS-CoV-2-host interactions R-HSA-9705683
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PI3K/AKT Signaling in Cancer R-HSA-2219528
Activation of BAD and translocation to mitochondria R-HSA-111447
VEGFR2 mediated vascular permeability R-HSA-5218920
KEAP1-NFE2L2 pathway R-HSA-9755511
Cellular responses to stimuli R-HSA-8953897
Activation of BH3-only proteins R-HSA-114452
Cyclin E associated events during G1/S transition R-HSA-69202
Cell Cycle R-HSA-1640170
AKT phosphorylates targets in the nucleus R-HSA-198693
Regulation of localization of FOXO transcription factors R-HSA-9614399
Infectious disease R-HSA-5663205
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
RNA Polymerase II Transcription R-HSA-73857
Regulation of TP53 Activity through Acetylation R-HSA-6804758
G beta:gamma signalling through PI3Kgamma R-HSA-392451
CTLA4 inhibitory signaling R-HSA-389513
Intracellular signaling by second messengers R-HSA-9006925
Signaling by ERBB2 R-HSA-1227986
Developmental Biology R-HSA-1266738
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Adaptive Immune System R-HSA-1280218
Cell Cycle, Mitotic R-HSA-69278
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
FOXO-mediated transcription R-HSA-9614085
Regulation of TP53 Degradation R-HSA-6804757
Programmed Cell Death R-HSA-5357801
Extra-nuclear estrogen signaling R-HSA-9009391
Regulation of gene expression in beta cells R-HSA-210745
VEGFA-VEGFR2 Pathway R-HSA-4420097
Regulation of PTEN stability and activity R-HSA-8948751
Intrinsic Pathway for Apoptosis R-HSA-109606
GPCR downstream signalling R-HSA-388396
Extra-nuclear estrogen signaling R-HSA-9009391
Downregulation of ERBB2 signaling R-HSA-8863795
Cellular responses to stimuli R-HSA-8953897
G1/S Transition R-HSA-69206
VEGFA-VEGFR2 Pathway R-HSA-4420097
PIP3 activates AKT signaling R-HSA-1257604
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by Nuclear Receptors R-HSA-9006931
CD28 co-stimulation R-HSA-389356
Infectious disease R-HSA-5663205
Regulation of gene expression in beta cells R-HSA-210745
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
PI3K/AKT Signaling in Cancer R-HSA-2219528
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Transcriptional regulation by RUNX2 R-HSA-8878166
Generic Transcription Pathway R-HSA-212436
Activation of BAD and translocation to mitochondria R-HSA-111447
AKT phosphorylates targets in the nucleus R-HSA-198693
CTLA4 inhibitory signaling R-HSA-389513
FLT3 Signaling R-HSA-9607240
Regulation of localization of FOXO transcription factors R-HSA-9614399
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Intracellular signaling by second messengers R-HSA-9006925
Signaling by GPCR R-HSA-372790
Programmed Cell Death R-HSA-5357801
SARS-CoV-2 Infection R-HSA-9694516
Regulation of TP53 Degradation R-HSA-6804757
Cell Cycle, Mitotic R-HSA-69278
Signaling by VEGF R-HSA-194138
Signal Transduction R-HSA-162582
S Phase R-HSA-69242
Membrane Trafficking R-HSA-199991
SARS-CoV-2-host interactions R-HSA-9705683
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Vesicle-mediated transport R-HSA-5653656
Signaling by ERBB2 R-HSA-1227986
Gene expression (Transcription) R-HSA-74160
Regulation of TP53 Expression and Degradation R-HSA-6806003
FOXO-mediated transcription R-HSA-9614085
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Costimulation by the CD28 family R-HSA-388841
Cell Cycle R-HSA-1640170
RNA Polymerase II Transcription R-HSA-73857
Regulation of TP53 Activity R-HSA-5633007
KEAP1-NFE2L2 pathway R-HSA-9755511
AKT phosphorylates targets in the cytosol R-HSA-198323
PTEN Regulation R-HSA-6807070
Regulation of beta-cell development R-HSA-186712
Apoptosis R-HSA-109581
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Negative regulation of the PI3K/AKT network R-HSA-199418
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
Adaptive Immune System R-HSA-1280218
Transcriptional Regulation by TP53 R-HSA-3700989
TP53 Regulates Metabolic Genes R-HSA-5628897
Regulation of TP53 Activity through Acetylation R-HSA-6804758
AKT-mediated inactivation of FOXO1A R-HSA-211163
Activation of BH3-only proteins R-HSA-114452
Developmental Biology R-HSA-1266738
Cyclin E associated events during G1/S transition R-HSA-69202
Cellular responses to stress R-HSA-2262752
SARS-CoV Infections R-HSA-9679506
VEGFR2 mediated vascular permeability R-HSA-5218920
Immune System R-HSA-168256
Rab regulation of trafficking R-HSA-9007101
ESR-mediated signaling R-HSA-8939211
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
Cellular response to chemical stress R-HSA-9711123
G-protein beta:gamma signalling R-HSA-397795
CD28 dependent PI3K/Akt signaling R-HSA-389357
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Mitotic G1 phase and G1/S transition R-HSA-453279
Disease R-HSA-1643685
G-protein beta:gamma signalling R-HSA-397795
Regulation of gene expression in beta cells R-HSA-210745
Vesicle-mediated transport R-HSA-5653656
Apoptosis R-HSA-109581
S Phase R-HSA-69242
Gene expression (Transcription) R-HSA-74160
GPCR downstream signalling R-HSA-388396
Intrinsic Pathway for Apoptosis R-HSA-109606
Cellular response to chemical stress R-HSA-9711123
Regulation of TP53 Expression and Degradation R-HSA-6806003
VEGFR2 mediated vascular permeability R-HSA-5218920
FLT3 Signaling R-HSA-9607240
Cell Cycle R-HSA-1640170
Intracellular signaling by second messengers R-HSA-9006925
Regulation of localization of FOXO transcription factors R-HSA-9614399
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Signaling by ERBB2 R-HSA-1227986
AKT phosphorylates targets in the cytosol R-HSA-198323
Costimulation by the CD28 family R-HSA-388841
Regulation of TP53 Activity R-HSA-5633007
Mitotic G1 phase and G1/S transition R-HSA-453279
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
Signaling by VEGF R-HSA-194138
Signal Transduction R-HSA-162582
AKT-mediated inactivation of FOXO1A R-HSA-211163
SARS-CoV-2 Infection R-HSA-9694516
RNA Polymerase II Transcription R-HSA-73857
PI3K/AKT Signaling in Cancer R-HSA-2219528
Regulation of beta-cell development R-HSA-186712
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Extra-nuclear estrogen signaling R-HSA-9009391
Cellular responses to stimuli R-HSA-8953897
G1/S Transition R-HSA-69206
Regulation of TP53 Degradation R-HSA-6804757
Cellular responses to stress R-HSA-2262752
CD28 co-stimulation R-HSA-389356
CTLA4 inhibitory signaling R-HSA-389513
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PIP3 activates AKT signaling R-HSA-1257604
Signaling by Nuclear Receptors R-HSA-9006931
Developmental Biology R-HSA-1266738
CD28 dependent PI3K/Akt signaling R-HSA-389357
Transcriptional regulation by RUNX2 R-HSA-8878166
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Downregulation of ERBB2 signaling R-HSA-8863795
Rab regulation of trafficking R-HSA-9007101
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
Membrane Trafficking R-HSA-199991
Transcriptional Regulation by TP53 R-HSA-3700989
SARS-CoV Infections R-HSA-9679506
TP53 Regulates Metabolic Genes R-HSA-5628897
Immune System R-HSA-168256
Negative regulation of the PI3K/AKT network R-HSA-199418
SARS-CoV-2-host interactions R-HSA-9705683
Adaptive Immune System R-HSA-1280218
Infectious disease R-HSA-5663205
VEGFA-VEGFR2 Pathway R-HSA-4420097
Cytokine Signaling in Immune system R-HSA-1280215
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Generic Transcription Pathway R-HSA-212436
Regulation of PTEN stability and activity R-HSA-8948751
KEAP1-NFE2L2 pathway R-HSA-9755511
Activation of BH3-only proteins R-HSA-114452
Programmed Cell Death R-HSA-5357801
FOXO-mediated transcription R-HSA-9614085
AKT phosphorylates targets in the nucleus R-HSA-198693
ESR-mediated signaling R-HSA-8939211
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Cell Cycle, Mitotic R-HSA-69278
PTEN Regulation R-HSA-6807070
Cyclin E associated events during G1/S transition R-HSA-69202
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by GPCR R-HSA-372790
Activation of BAD and translocation to mitochondria R-HSA-111447
Disease R-HSA-1643685
Immune System R-HSA-168256
Intracellular signaling by second messengers R-HSA-9006925
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
FLT3 Signaling R-HSA-9607240
CD28 co-stimulation R-HSA-389356
RUNX2 regulates genes involved in cell migration R-HSA-8941332
PTEN Regulation R-HSA-6807070
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Signaling by GPCR R-HSA-372790
VEGFR2 mediated vascular permeability R-HSA-5218920
FOXO-mediated transcription R-HSA-9614085
KEAP1-NFE2L2 pathway R-HSA-9755511
Signaling by VEGF R-HSA-194138
Developmental Biology R-HSA-1266738
Cyclin E associated events during G1/S transition R-HSA-69202
Costimulation by the CD28 family R-HSA-388841
Cell Cycle, Mitotic R-HSA-69278
Transcriptional regulation by RUNX2 R-HSA-8878166
TP53 Regulates Metabolic Genes R-HSA-5628897
SARS-CoV Infections R-HSA-9679506
Extra-nuclear estrogen signaling R-HSA-9009391
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI3K/AKT Signaling in Cancer R-HSA-2219528
Regulation of beta-cell development R-HSA-186712
Cellular responses to stress R-HSA-2262752
Generic Transcription Pathway R-HSA-212436
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
G-protein beta:gamma signalling R-HSA-397795
Signaling by Nuclear Receptors R-HSA-9006931
Transcriptional Regulation by TP53 R-HSA-3700989
Disease R-HSA-1643685
Regulation of PTEN stability and activity R-HSA-8948751
Regulation of gene expression in beta cells R-HSA-210745
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Mitotic G1 phase and G1/S transition R-HSA-453279
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
AKT phosphorylates targets in the nucleus R-HSA-198693
Regulation of TP53 Expression and Degradation R-HSA-6806003
Intrinsic Pathway for Apoptosis R-HSA-109606
Regulation of localization of FOXO transcription factors R-HSA-9614399
Apoptosis R-HSA-109581
Cell Cycle R-HSA-1640170
GPCR downstream signalling R-HSA-388396
Downregulation of ERBB2 signaling R-HSA-8863795
Vesicle-mediated transport R-HSA-5653656
ESR-mediated signaling R-HSA-8939211
Gene expression (Transcription) R-HSA-74160
VEGFA-VEGFR2 Pathway R-HSA-4420097
Regulation of TP53 Activity R-HSA-5633007
CD28 dependent PI3K/Akt signaling R-HSA-389357
Activation of BAD and translocation to mitochondria R-HSA-111447
Membrane Trafficking R-HSA-199991
Regulation of TP53 Degradation R-HSA-6804757
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Signal Transduction R-HSA-162582
Activation of BH3-only proteins R-HSA-114452
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Programmed Cell Death R-HSA-5357801
SARS-CoV-2-host interactions R-HSA-9705683
S Phase R-HSA-69242
Rab regulation of trafficking R-HSA-9007101
Adaptive Immune System R-HSA-1280218
Cellular response to chemical stress R-HSA-9711123
CTLA4 inhibitory signaling R-HSA-389513
SARS-CoV-2 Infection R-HSA-9694516
Infectious disease R-HSA-5663205
G1/S Transition R-HSA-69206
AKT-mediated inactivation of FOXO1A R-HSA-211163
Signaling by ERBB2 R-HSA-1227986
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
AKT phosphorylates targets in the cytosol R-HSA-198323
Cytokine Signaling in Immune system R-HSA-1280215
RNA Polymerase II Transcription R-HSA-73857
PIP3 activates AKT signaling R-HSA-1257604
Cellular responses to stimuli R-HSA-8953897
Disease R-HSA-1643685
Membrane Trafficking R-HSA-199991
G1/S Transition R-HSA-69206
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
SARS-CoV-2-host interactions R-HSA-9705683
Signal Transduction R-HSA-162582
Apoptosis R-HSA-109581
G-protein beta:gamma signalling R-HSA-397795
Infectious disease R-HSA-5663205
Regulation of gene expression in beta cells R-HSA-210745
Regulation of localization of FOXO transcription factors R-HSA-9614399
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Extra-nuclear estrogen signaling R-HSA-9009391
Cell Cycle, Mitotic R-HSA-69278
Vesicle-mediated transport R-HSA-5653656
KEAP1-NFE2L2 pathway R-HSA-9755511
Gene expression (Transcription) R-HSA-74160
Generic Transcription Pathway R-HSA-212436
Regulation of TP53 Activity R-HSA-5633007
Programmed Cell Death R-HSA-5357801
FOXO-mediated transcription R-HSA-9614085
AKT-mediated inactivation of FOXO1A R-HSA-211163
PTEN Regulation R-HSA-6807070
VEGFA-VEGFR2 Pathway R-HSA-4420097
Transcriptional regulation by RUNX2 R-HSA-8878166
CTLA4 inhibitory signaling R-HSA-389513
Transcriptional Regulation by TP53 R-HSA-3700989
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Negative regulation of the PI3K/AKT network R-HSA-199418
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
CD28 dependent PI3K/Akt signaling R-HSA-389357
ESR-mediated signaling R-HSA-8939211
CD28 co-stimulation R-HSA-389356
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
VEGFR2 mediated vascular permeability R-HSA-5218920
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Regulation of PTEN stability and activity R-HSA-8948751
GPCR downstream signalling R-HSA-388396
Developmental Biology R-HSA-1266738
FLT3 Signaling R-HSA-9607240
Activation of BH3-only proteins R-HSA-114452
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Immune System R-HSA-168256
Activation of BAD and translocation to mitochondria R-HSA-111447
S Phase R-HSA-69242
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Regulation of TP53 Expression and Degradation R-HSA-6806003
Intracellular signaling by second messengers R-HSA-9006925
Cellular response to chemical stress R-HSA-9711123
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by GPCR R-HSA-372790
AKT phosphorylates targets in the cytosol R-HSA-198323
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Adaptive Immune System R-HSA-1280218
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Regulation of TP53 Degradation R-HSA-6804757
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Intrinsic Pathway for Apoptosis R-HSA-109606
Cellular responses to stress R-HSA-2262752
AKT phosphorylates targets in the nucleus R-HSA-198693
Cyclin E associated events during G1/S transition R-HSA-69202
Cellular responses to stimuli R-HSA-8953897
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by VEGF R-HSA-194138
Cytokine Signaling in Immune system R-HSA-1280215
TP53 Regulates Metabolic Genes R-HSA-5628897
Signaling by ERBB2 R-HSA-1227986
Mitotic G1 phase and G1/S transition R-HSA-453279
Cell Cycle R-HSA-1640170
PIP3 activates AKT signaling R-HSA-1257604
Regulation of beta-cell development R-HSA-186712
Costimulation by the CD28 family R-HSA-388841
SARS-CoV Infections R-HSA-9679506
Rab regulation of trafficking R-HSA-9007101
RNA Polymerase II Transcription R-HSA-73857
Signaling by Nuclear Receptors R-HSA-9006931
SARS-CoV-2 Infection R-HSA-9694516
Downregulation of ERBB2 signaling R-HSA-8863795
Transcriptional regulation by RUNX2 R-HSA-8878166
GPCR downstream signalling R-HSA-388396
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
S Phase R-HSA-69242
Cytokine Signaling in Immune system R-HSA-1280215
Regulation of beta-cell development R-HSA-186712
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Extra-nuclear estrogen signaling R-HSA-9009391
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
PI3K/AKT Signaling in Cancer R-HSA-2219528
CD28 co-stimulation R-HSA-389356
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Adaptive Immune System R-HSA-1280218
Activation of BAD and translocation to mitochondria R-HSA-111447
SARS-CoV-2-host interactions R-HSA-9705683
G1/S Transition R-HSA-69206
Downregulation of ERBB2 signaling R-HSA-8863795
RNA Polymerase II Transcription R-HSA-73857
Mitotic G1 phase and G1/S transition R-HSA-453279
VEGFA-VEGFR2 Pathway R-HSA-4420097
SARS-CoV Infections R-HSA-9679506
Cell Cycle, Mitotic R-HSA-69278
Regulation of gene expression in beta cells R-HSA-210745
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
VEGFR2 mediated vascular permeability R-HSA-5218920
Programmed Cell Death R-HSA-5357801
Cellular responses to stress R-HSA-2262752
Activation of BH3-only proteins R-HSA-114452
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
AKT-mediated inactivation of FOXO1A R-HSA-211163
TP53 Regulates Metabolic Genes R-HSA-5628897
Gene expression (Transcription) R-HSA-74160
Signal Transduction R-HSA-162582
AKT phosphorylates targets in the cytosol R-HSA-198323
Negative regulation of the PI3K/AKT network R-HSA-199418
Immune System R-HSA-168256
PIP3 activates AKT signaling R-HSA-1257604
Membrane Trafficking R-HSA-199991
Cellular response to chemical stress R-HSA-9711123
Signaling by GPCR R-HSA-372790
Cyclin E associated events during G1/S transition R-HSA-69202
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
Generic Transcription Pathway R-HSA-212436
FLT3 Signaling R-HSA-9607240
Costimulation by the CD28 family R-HSA-388841
Regulation of localization of FOXO transcription factors R-HSA-9614399
Intrinsic Pathway for Apoptosis R-HSA-109606
ESR-mediated signaling R-HSA-8939211
FOXO-mediated transcription R-HSA-9614085
Apoptosis R-HSA-109581
PTEN Regulation R-HSA-6807070
Signaling by Nuclear Receptors R-HSA-9006931
Vesicle-mediated transport R-HSA-5653656
Transcriptional Regulation by TP53 R-HSA-3700989
G beta:gamma signalling through PI3Kgamma R-HSA-392451
AKT phosphorylates targets in the nucleus R-HSA-198693
G-protein beta:gamma signalling R-HSA-397795
Regulation of PTEN stability and activity R-HSA-8948751
Regulation of TP53 Activity R-HSA-5633007
CTLA4 inhibitory signaling R-HSA-389513
Disease R-HSA-1643685
Infectious disease R-HSA-5663205
Regulation of TP53 Expression and Degradation R-HSA-6806003
Intracellular signaling by second messengers R-HSA-9006925
Cell Cycle R-HSA-1640170
Cellular responses to stimuli R-HSA-8953897
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Signaling by VEGF R-HSA-194138
KEAP1-NFE2L2 pathway R-HSA-9755511
Rab regulation of trafficking R-HSA-9007101
Signaling by ERBB2 R-HSA-1227986
CD28 dependent PI3K/Akt signaling R-HSA-389357
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Regulation of TP53 Degradation R-HSA-6804757
SARS-CoV-2 Infection R-HSA-9694516
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Developmental Biology R-HSA-1266738
G-protein beta:gamma signalling R-HSA-397795
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Negative regulation of the PI3K/AKT network R-HSA-199418
CD28 dependent PI3K/Akt signaling R-HSA-389357
Costimulation by the CD28 family R-HSA-388841
PI3K/AKT Signaling in Cancer R-HSA-2219528
Programmed Cell Death R-HSA-5357801
RNA Polymerase II Transcription R-HSA-73857
Regulation of PTEN stability and activity R-HSA-8948751
Signaling by ERBB2 R-HSA-1227986
KEAP1-NFE2L2 pathway R-HSA-9755511
PTEN Regulation R-HSA-6807070
Activation of BAD and translocation to mitochondria R-HSA-111447
PIP3 activates AKT signaling R-HSA-1257604
SARS-CoV-2-host interactions R-HSA-9705683
Vesicle-mediated transport R-HSA-5653656
Signaling by Nuclear Receptors R-HSA-9006931
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Regulation of localization of FOXO transcription factors R-HSA-9614399
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
Membrane Trafficking R-HSA-199991
Cyclin E associated events during G1/S transition R-HSA-69202
AKT phosphorylates targets in the cytosol R-HSA-198323
Generic Transcription Pathway R-HSA-212436
Regulation of gene expression in beta cells R-HSA-210745
Regulation of TP53 Expression and Degradation R-HSA-6806003
Signaling by GPCR R-HSA-372790
Rab regulation of trafficking R-HSA-9007101
CD28 co-stimulation R-HSA-389356
FOXO-mediated transcription R-HSA-9614085
FLT3 Signaling R-HSA-9607240
GPCR downstream signalling R-HSA-388396
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Cell Cycle, Mitotic R-HSA-69278
TP53 Regulates Metabolic Genes R-HSA-5628897
Disease R-HSA-1643685
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
ESR-mediated signaling R-HSA-8939211
Transcriptional regulation by RUNX2 R-HSA-8878166
Immune System R-HSA-168256
Intracellular signaling by second messengers R-HSA-9006925
Infectious disease R-HSA-5663205
Signaling by VEGF R-HSA-194138
Gene expression (Transcription) R-HSA-74160
Transcriptional Regulation by TP53 R-HSA-3700989
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Apoptosis R-HSA-109581
VEGFA-VEGFR2 Pathway R-HSA-4420097
Intrinsic Pathway for Apoptosis R-HSA-109606
SARS-CoV Infections R-HSA-9679506
AKT-mediated inactivation of FOXO1A R-HSA-211163
Cell Cycle R-HSA-1640170
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
CTLA4 inhibitory signaling R-HSA-389513
Extra-nuclear estrogen signaling R-HSA-9009391
Developmental Biology R-HSA-1266738
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
G1/S Transition R-HSA-69206
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
VEGFR2 mediated vascular permeability R-HSA-5218920
Cytokine Signaling in Immune system R-HSA-1280215
SARS-CoV-2 Infection R-HSA-9694516
Downregulation of ERBB2 signaling R-HSA-8863795
Regulation of TP53 Activity R-HSA-5633007
Cellular responses to stimuli R-HSA-8953897
Regulation of beta-cell development R-HSA-186712
Mitotic G1 phase and G1/S transition R-HSA-453279
Signal Transduction R-HSA-162582
AKT phosphorylates targets in the nucleus R-HSA-198693
Regulation of TP53 Degradation R-HSA-6804757
Activation of BH3-only proteins R-HSA-114452
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Cellular response to chemical stress R-HSA-9711123
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Cellular responses to stress R-HSA-2262752
S Phase R-HSA-69242
Adaptive Immune System R-HSA-1280218
PIP3 activates AKT signaling R-HSA-1257604
Intrinsic Pathway for Apoptosis R-HSA-109606
Signal Transduction R-HSA-162582
Adaptive Immune System R-HSA-1280218
Membrane Trafficking R-HSA-199991
FLT3 Signaling R-HSA-9607240
TP53 Regulates Metabolic Genes R-HSA-5628897
Regulation of TP53 Activity through Acetylation R-HSA-6804758
SARS-CoV Infections R-HSA-9679506
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Regulation of TP53 Expression and Degradation R-HSA-6806003
Signaling by ERBB2 R-HSA-1227986
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
SARS-CoV-2-host interactions R-HSA-9705683
Cell Cycle, Mitotic R-HSA-69278
Transcriptional regulation by RUNX2 R-HSA-8878166
ESR-mediated signaling R-HSA-8939211
CTLA4 inhibitory signaling R-HSA-389513
Costimulation by the CD28 family R-HSA-388841
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by Nuclear Receptors R-HSA-9006931
CD28 co-stimulation R-HSA-389356
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
Cytokine Signaling in Immune system R-HSA-1280215
Programmed Cell Death R-HSA-5357801
PTEN Regulation R-HSA-6807070
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Infectious disease R-HSA-5663205
Cellular responses to stress R-HSA-2262752
Cell Cycle R-HSA-1640170
RUNX2 regulates genes involved in cell migration R-HSA-8941332
FOXO-mediated transcription R-HSA-9614085
G beta:gamma signalling through PI3Kgamma R-HSA-392451
AKT-mediated inactivation of FOXO1A R-HSA-211163
Vesicle-mediated transport R-HSA-5653656
Activation of BH3-only proteins R-HSA-114452
Apoptosis R-HSA-109581
S Phase R-HSA-69242
Transcriptional Regulation by TP53 R-HSA-3700989
Activation of BAD and translocation to mitochondria R-HSA-111447
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Cellular response to chemical stress R-HSA-9711123
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
Regulation of beta-cell development R-HSA-186712
Regulation of gene expression in beta cells R-HSA-210745
AKT phosphorylates targets in the nucleus R-HSA-198693
GPCR downstream signalling R-HSA-388396
Cyclin E associated events during G1/S transition R-HSA-69202
Regulation of TP53 Activity R-HSA-5633007
VEGFR2 mediated vascular permeability R-HSA-5218920
CD28 dependent PI3K/Akt signaling R-HSA-389357
Cellular responses to stimuli R-HSA-8953897
Rab regulation of trafficking R-HSA-9007101
Generic Transcription Pathway R-HSA-212436
Regulation of TP53 Degradation R-HSA-6804757
KEAP1-NFE2L2 pathway R-HSA-9755511
Mitotic G1 phase and G1/S transition R-HSA-453279
Gene expression (Transcription) R-HSA-74160
G-protein beta:gamma signalling R-HSA-397795
SARS-CoV-2 Infection R-HSA-9694516
Negative regulation of the PI3K/AKT network R-HSA-199418
Extra-nuclear estrogen signaling R-HSA-9009391
AKT phosphorylates targets in the cytosol R-HSA-198323
Signaling by GPCR R-HSA-372790
VEGFA-VEGFR2 Pathway R-HSA-4420097
Intracellular signaling by second messengers R-HSA-9006925
Disease R-HSA-1643685
Regulation of localization of FOXO transcription factors R-HSA-9614399
G1/S Transition R-HSA-69206
RNA Polymerase II Transcription R-HSA-73857
Immune System R-HSA-168256
Signaling by VEGF R-HSA-194138
Developmental Biology R-HSA-1266738
Regulation of PTEN stability and activity R-HSA-8948751
Downregulation of ERBB2 signaling R-HSA-8863795
RUNX2 regulates genes involved in cell migration R-HSA-8941332
Generic Transcription Pathway R-HSA-212436
Cellular responses to stimuli R-HSA-8953897
Developmental Biology R-HSA-1266738
Activation of BAD and translocation to mitochondria R-HSA-111447
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Immune System R-HSA-168256
CD28 co-stimulation R-HSA-389356
Regulation of TP53 Activity through Acetylation R-HSA-6804758
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
VEGFR2 mediated vascular permeability R-HSA-5218920
PIP3 activates AKT signaling R-HSA-1257604
Cytokine Signaling in Immune system R-HSA-1280215
Activation of BH3-only proteins R-HSA-114452
Regulation of TP53 Activity R-HSA-5633007
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803
G-protein beta:gamma signalling R-HSA-397795
AKT phosphorylates targets in the nucleus R-HSA-198693
FLT3 Signaling R-HSA-9607240
Signaling by ERBB2 R-HSA-1227986
Adaptive Immune System R-HSA-1280218
Infectious disease R-HSA-5663205
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400
Apoptosis R-HSA-109581
Cell Cycle, Mitotic R-HSA-69278
SARS-CoV Infections R-HSA-9679506
ESR-mediated signaling R-HSA-8939211
Membrane Trafficking R-HSA-199991
Regulation of localization of FOXO transcription factors R-HSA-9614399
Intrinsic Pathway for Apoptosis R-HSA-109606
CD28 dependent PI3K/Akt signaling R-HSA-389357
Rab regulation of trafficking R-HSA-9007101
Regulation of TP53 Degradation R-HSA-6804757
Extra-nuclear estrogen signaling R-HSA-9009391
Disease R-HSA-1643685
Gene expression (Transcription) R-HSA-74160
SARS-CoV-2-host interactions R-HSA-9705683
Regulation of gene expression in beta cells R-HSA-210745
Negative regulation of the PI3K/AKT network R-HSA-199418
Cyclin E associated events during G1/S transition R-HSA-69202
RNA Polymerase II Transcription R-HSA-73857
G beta:gamma signalling through PI3Kgamma R-HSA-392451
Signaling by VEGF R-HSA-194138
Downregulation of ERBB2 signaling R-HSA-8863795
Mitotic G1 phase and G1/S transition R-HSA-453279
SARS-CoV-2 Infection R-HSA-9694516
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638
Cell Cycle R-HSA-1640170
Intracellular signaling by second messengers R-HSA-9006925
Cellular responses to stress R-HSA-2262752
PTEN Regulation R-HSA-6807070
Cellular response to chemical stress R-HSA-9711123
FOXO-mediated transcription R-HSA-9614085
AKT-mediated inactivation of FOXO1A R-HSA-211163
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198
Transcriptional Regulation by TP53 R-HSA-3700989
Costimulation by the CD28 family R-HSA-388841
Programmed Cell Death R-HSA-5357801
Regulation of PTEN stability and activity R-HSA-8948751
Signal Transduction R-HSA-162582
TP53 Regulates Metabolic Genes R-HSA-5628897
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI3K/AKT Signaling in Cancer R-HSA-2219528
S Phase R-HSA-69242
AKT phosphorylates targets in the cytosol R-HSA-198323
Regulation of beta-cell development R-HSA-186712
VEGFA-VEGFR2 Pathway R-HSA-4420097
Signaling by GPCR R-HSA-372790
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759
CTLA4 inhibitory signaling R-HSA-389513
GPCR downstream signalling R-HSA-388396
Transcriptional regulation by RUNX2 R-HSA-8878166
KEAP1-NFE2L2 pathway R-HSA-9755511
G1/S Transition R-HSA-69206
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779
Regulation of TP53 Expression and Degradation R-HSA-6806003
Vesicle-mediated transport R-HSA-5653656
Signaling by Nuclear Receptors R-HSA-9006931

Expression Atlas ENSG00000117020
LRG display in Ensembl gene LRG_1396
NCBI gene (formerly Entrezgene) 10000
GeneCards 393
HGNC Symbol HGNC:393
MIM gene 611223
MIM morbid 615937
UniProtKB Gene Name Q9Y243
WikiGene 10000
Gene: YES1
Ensembl ID : ENSG00000176105
Description: YES proto-oncogene 1, Src family tyrosine kinase
Gene Synonyms: C-YES,HST441,YES
1 APIs:
258 Possible Orthologues:

Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Infectious disease R-HSA-5663205
Signal Transduction R-HSA-162582
RUNX2 regulates osteoblast differentiation R-HSA-8940973
PECAM1 interactions R-HSA-210990
Adaptive Immune System R-HSA-1280218
EPHB-mediated forward signaling R-HSA-3928662
Parasite infection R-HSA-9664407
Generic Transcription Pathway R-HSA-212436
EPH-ephrin mediated repulsion of cells R-HSA-3928665
FCGR3A-mediated phagocytosis R-HSA-9664422
Nervous system development R-HSA-9675108
Signaling by ERBB2 R-HSA-1227986
Regulation of signaling by CBL R-HSA-912631
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Axon guidance R-HSA-422475
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Cytokine Signaling in Immune system R-HSA-1280215
Gene expression (Transcription) R-HSA-74160
FCGR activation R-HSA-2029481
RUNX2 regulates bone development R-HSA-8941326
Regulation of KIT signaling R-HSA-1433559
Immune System R-HSA-168256
Signaling by Interleukins R-HSA-449147
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
EPH-Ephrin signaling R-HSA-2682334
Leishmania infection R-HSA-9658195
Leishmania parasite growth and survival R-HSA-9664433
Signaling by SCF-KIT R-HSA-1433557
Signaling by KIT in disease R-HSA-9669938
CTLA4 inhibitory signaling R-HSA-389513
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
EPHA-mediated growth cone collapse R-HSA-3928663
Costimulation by the CD28 family R-HSA-388841
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Leishmania phagocytosis R-HSA-9664417
Disease R-HSA-1643685
Cell surface interactions at the vascular wall R-HSA-202733
Transcriptional regulation by RUNX2 R-HSA-8878166
CD28 co-stimulation R-HSA-389356
Developmental Biology R-HSA-1266738
RNA Polymerase II Transcription R-HSA-73857
Hemostasis R-HSA-109582
Innate Immune System R-HSA-168249
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PECAM1 interactions R-HSA-210990
EPH-Ephrin signaling R-HSA-2682334
Axon guidance R-HSA-422475
Adaptive Immune System R-HSA-1280218
Parasite infection R-HSA-9664407
CD28 co-stimulation R-HSA-389356
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by KIT in disease R-HSA-9669938
Costimulation by the CD28 family R-HSA-388841
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Gene expression (Transcription) R-HSA-74160
Leishmania infection R-HSA-9658195
CTLA4 inhibitory signaling R-HSA-389513
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Infectious disease R-HSA-5663205
Transcriptional regulation by RUNX2 R-HSA-8878166
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Hemostasis R-HSA-109582
EPHB-mediated forward signaling R-HSA-3928662
Regulation of KIT signaling R-HSA-1433559
RUNX2 regulates bone development R-HSA-8941326
Innate Immune System R-HSA-168249
Signaling by ERBB2 R-HSA-1227986
Immune System R-HSA-168256
FCGR3A-mediated phagocytosis R-HSA-9664422
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signal Transduction R-HSA-162582
Leishmania phagocytosis R-HSA-9664417
Generic Transcription Pathway R-HSA-212436
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Disease R-HSA-1643685
Cell surface interactions at the vascular wall R-HSA-202733
Regulation of signaling by CBL R-HSA-912631
Signaling by Interleukins R-HSA-449147
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
FCGR activation R-HSA-2029481
Signaling by SCF-KIT R-HSA-1433557
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Developmental Biology R-HSA-1266738
RNA Polymerase II Transcription R-HSA-73857
Cytokine Signaling in Immune system R-HSA-1280215
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
CD28 co-stimulation R-HSA-389356
Adaptive Immune System R-HSA-1280218
Leishmania parasite growth and survival R-HSA-9664433
Costimulation by the CD28 family R-HSA-388841
Nervous system development R-HSA-9675108
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Disease R-HSA-1643685
Generic Transcription Pathway R-HSA-212436
Signal Transduction R-HSA-162582
RUNX2 regulates bone development R-HSA-8941326
FCGR activation R-HSA-2029481
Signaling by ERBB2 R-HSA-1227986
Signaling by Interleukins R-HSA-449147
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
EPHA-mediated growth cone collapse R-HSA-3928663
FCGR3A-mediated phagocytosis R-HSA-9664422
Immune System R-HSA-168256
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
RNA Polymerase II Transcription R-HSA-73857
Leishmania infection R-HSA-9658195
Innate Immune System R-HSA-168249
Signaling by SCF-KIT R-HSA-1433557
Gene expression (Transcription) R-HSA-74160
CTLA4 inhibitory signaling R-HSA-389513
PECAM1 interactions R-HSA-210990
Developmental Biology R-HSA-1266738
Transcriptional regulation by RUNX2 R-HSA-8878166
Axon guidance R-HSA-422475
Cell surface interactions at the vascular wall R-HSA-202733
Signaling by KIT in disease R-HSA-9669938
Infectious disease R-HSA-5663205
Cytokine Signaling in Immune system R-HSA-1280215
Leishmania phagocytosis R-HSA-9664417
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Regulation of KIT signaling R-HSA-1433559
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Hemostasis R-HSA-109582
EPH-Ephrin signaling R-HSA-2682334
FCGR3A-mediated phagocytosis R-HSA-9664422
Signal Transduction R-HSA-162582
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by KIT in disease R-HSA-9669938
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Nervous system development R-HSA-9675108
Regulation of signaling by CBL R-HSA-912631
RNA Polymerase II Transcription R-HSA-73857
Cell surface interactions at the vascular wall R-HSA-202733
Cytokine Signaling in Immune system R-HSA-1280215
Gene expression (Transcription) R-HSA-74160
CTLA4 inhibitory signaling R-HSA-389513
Disease R-HSA-1643685
CD28 co-stimulation R-HSA-389356
Axon guidance R-HSA-422475
EPHB-mediated forward signaling R-HSA-3928662
Innate Immune System R-HSA-168249
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Costimulation by the CD28 family R-HSA-388841
Adaptive Immune System R-HSA-1280218
Developmental Biology R-HSA-1266738
Signaling by ERBB2 R-HSA-1227986
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
EPH-Ephrin signaling R-HSA-2682334
Parasite infection R-HSA-9664407
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by SCF-KIT R-HSA-1433557
EPHA-mediated growth cone collapse R-HSA-3928663
Transcriptional regulation by RUNX2 R-HSA-8878166
Immune System R-HSA-168256
Hemostasis R-HSA-109582
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Signaling by Interleukins R-HSA-449147
Leishmania parasite growth and survival R-HSA-9664433
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Generic Transcription Pathway R-HSA-212436
PECAM1 interactions R-HSA-210990
RUNX2 regulates bone development R-HSA-8941326
Leishmania infection R-HSA-9658195
Regulation of KIT signaling R-HSA-1433559
Leishmania phagocytosis R-HSA-9664417
FCGR activation R-HSA-2029481
Infectious disease R-HSA-5663205
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
CD28 co-stimulation R-HSA-389356
Cell surface interactions at the vascular wall R-HSA-202733
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Axon guidance R-HSA-422475
EPHA-mediated growth cone collapse R-HSA-3928663
Transcriptional regulation by RUNX2 R-HSA-8878166
Signaling by KIT in disease R-HSA-9669938
Infectious disease R-HSA-5663205
Gene expression (Transcription) R-HSA-74160
Nervous system development R-HSA-9675108
RNA Polymerase II Transcription R-HSA-73857
Signaling by ERBB2 R-HSA-1227986
PECAM1 interactions R-HSA-210990
Hemostasis R-HSA-109582
CTLA4 inhibitory signaling R-HSA-389513
Generic Transcription Pathway R-HSA-212436
EPH-Ephrin signaling R-HSA-2682334
Leishmania infection R-HSA-9658195
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Immune System R-HSA-168256
FCGR activation R-HSA-2029481
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Interleukins R-HSA-449147
Signal Transduction R-HSA-162582
FCGR3A-mediated phagocytosis R-HSA-9664422
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by SCF-KIT R-HSA-1433557
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Innate Immune System R-HSA-168249
Costimulation by the CD28 family R-HSA-388841
Parasite infection R-HSA-9664407
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Regulation of KIT signaling R-HSA-1433559
Leishmania parasite growth and survival R-HSA-9664433
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FCGR3A-mediated IL10 synthesis R-HSA-9664323
EPHB-mediated forward signaling R-HSA-3928662
Developmental Biology R-HSA-1266738
RUNX2 regulates bone development R-HSA-8941326
Adaptive Immune System R-HSA-1280218
Disease R-HSA-1643685
Leishmania phagocytosis R-HSA-9664417
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Signaling by ERBB2 R-HSA-1227986
CD28 co-stimulation R-HSA-389356
Transcriptional regulation by RUNX2 R-HSA-8878166
Generic Transcription Pathway R-HSA-212436
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Interleukins R-HSA-449147
EPHA-mediated growth cone collapse R-HSA-3928663
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signal Transduction R-HSA-162582
FCGR3A-mediated phagocytosis R-HSA-9664422
Disease R-HSA-1643685
Regulation of signaling by CBL R-HSA-912631
FCGR activation R-HSA-2029481
Leishmania phagocytosis R-HSA-9664417
Regulation of KIT signaling R-HSA-1433559
Infectious disease R-HSA-5663205
CTLA4 inhibitory signaling R-HSA-389513
Costimulation by the CD28 family R-HSA-388841
Axon guidance R-HSA-422475
EPH-Ephrin signaling R-HSA-2682334
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Innate Immune System R-HSA-168249
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Developmental Biology R-HSA-1266738
Signaling by SCF-KIT R-HSA-1433557
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
RNA Polymerase II Transcription R-HSA-73857
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Signaling by KIT in disease R-HSA-9669938
Adaptive Immune System R-HSA-1280218
Hemostasis R-HSA-109582
RUNX2 regulates bone development R-HSA-8941326
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
PECAM1 interactions R-HSA-210990
Leishmania infection R-HSA-9658195
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Gene expression (Transcription) R-HSA-74160
Cell surface interactions at the vascular wall R-HSA-202733
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
CD28 co-stimulation R-HSA-389356
PECAM1 interactions R-HSA-210990
Generic Transcription Pathway R-HSA-212436
FCGR3A-mediated IL10 synthesis R-HSA-9664323
RNA Polymerase II Transcription R-HSA-73857
Regulation of KIT signaling R-HSA-1433559
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Nervous system development R-HSA-9675108
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by SCF-KIT R-HSA-1433557
FCGR activation R-HSA-2029481
Leishmania infection R-HSA-9658195
Parasite infection R-HSA-9664407
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Axon guidance R-HSA-422475
Costimulation by the CD28 family R-HSA-388841
Hemostasis R-HSA-109582
Disease R-HSA-1643685
EPH-Ephrin signaling R-HSA-2682334
EPHB-mediated forward signaling R-HSA-3928662
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Infectious disease R-HSA-5663205
Leishmania phagocytosis R-HSA-9664417
FCGR3A-mediated phagocytosis R-HSA-9664422
Innate Immune System R-HSA-168249
Immune System R-HSA-168256
Gene expression (Transcription) R-HSA-74160
Regulation of signaling by CBL R-HSA-912631
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Developmental Biology R-HSA-1266738
Signaling by Interleukins R-HSA-449147
Signaling by KIT in disease R-HSA-9669938
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by ERBB2 R-HSA-1227986
Cytokine Signaling in Immune system R-HSA-1280215
CTLA4 inhibitory signaling R-HSA-389513
Transcriptional regulation by RUNX2 R-HSA-8878166
Signal Transduction R-HSA-162582
Cell surface interactions at the vascular wall R-HSA-202733
Adaptive Immune System R-HSA-1280218
RUNX2 regulates bone development R-HSA-8941326
Leishmania parasite growth and survival R-HSA-9664433
EPH-ephrin mediated repulsion of cells R-HSA-3928665
PECAM1 interactions R-HSA-210990
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Hemostasis R-HSA-109582
EPHB-mediated forward signaling R-HSA-3928662
Signal Transduction R-HSA-162582
Transcriptional regulation by RUNX2 R-HSA-8878166
RNA Polymerase II Transcription R-HSA-73857
Regulation of KIT signaling R-HSA-1433559
Signaling by SCF-KIT R-HSA-1433557
Innate Immune System R-HSA-168249
Axon guidance R-HSA-422475
Leishmania parasite growth and survival R-HSA-9664433
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates bone development R-HSA-8941326
CD28 co-stimulation R-HSA-389356
FCGR3A-mediated phagocytosis R-HSA-9664422
Disease R-HSA-1643685
Developmental Biology R-HSA-1266738
CTLA4 inhibitory signaling R-HSA-389513
EPH-Ephrin signaling R-HSA-2682334
Infectious disease R-HSA-5663205
FCGR3A-mediated IL10 synthesis R-HSA-9664323
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Generic Transcription Pathway R-HSA-212436
Cell surface interactions at the vascular wall R-HSA-202733
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Cytokine Signaling in Immune system R-HSA-1280215
Immune System R-HSA-168256
FCGR activation R-HSA-2029481
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Signaling by ERBB2 R-HSA-1227986
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Adaptive Immune System R-HSA-1280218
Leishmania phagocytosis R-HSA-9664417
EPHA-mediated growth cone collapse R-HSA-3928663
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Costimulation by the CD28 family R-HSA-388841
Signaling by KIT in disease R-HSA-9669938
Signaling by Interleukins R-HSA-449147
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Nervous system development R-HSA-9675108
Leishmania infection R-HSA-9658195
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Gene expression (Transcription) R-HSA-74160
Parasite infection R-HSA-9664407
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by Interleukins R-HSA-449147
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by KIT in disease R-HSA-9669938
Costimulation by the CD28 family R-HSA-388841
Regulation of KIT signaling R-HSA-1433559
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Developmental Biology R-HSA-1266738
Leishmania phagocytosis R-HSA-9664417
Axon guidance R-HSA-422475
RNA Polymerase II Transcription R-HSA-73857
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
RUNX2 regulates bone development R-HSA-8941326
Hemostasis R-HSA-109582
Nervous system development R-HSA-9675108
PECAM1 interactions R-HSA-210990
CTLA4 inhibitory signaling R-HSA-389513
Signaling by ERBB2 R-HSA-1227986
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Gene expression (Transcription) R-HSA-74160
Infectious disease R-HSA-5663205
EPH-Ephrin signaling R-HSA-2682334
FCGR activation R-HSA-2029481
Cell surface interactions at the vascular wall R-HSA-202733
Adaptive Immune System R-HSA-1280218
Signal Transduction R-HSA-162582
Transcriptional regulation by RUNX2 R-HSA-8878166
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signaling by SCF-KIT R-HSA-1433557
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Cytokine Signaling in Immune system R-HSA-1280215
Leishmania infection R-HSA-9658195
Generic Transcription Pathway R-HSA-212436
CD28 co-stimulation R-HSA-389356
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
EPH-ephrin mediated repulsion of cells R-HSA-3928665
FCGR3A-mediated phagocytosis R-HSA-9664422
Immune System R-HSA-168256
Leishmania parasite growth and survival R-HSA-9664433
Innate Immune System R-HSA-168249
Disease R-HSA-1643685
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
FCGR3A-mediated phagocytosis R-HSA-9664422
Signal Transduction R-HSA-162582
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Cell surface interactions at the vascular wall R-HSA-202733
Leishmania phagocytosis R-HSA-9664417
CTLA4 inhibitory signaling R-HSA-389513
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Regulation of signaling by CBL R-HSA-912631
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Signaling by SCF-KIT R-HSA-1433557
Gene expression (Transcription) R-HSA-74160
PECAM1 interactions R-HSA-210990
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Hemostasis R-HSA-109582
Signaling by KIT in disease R-HSA-9669938
EPHB-mediated forward signaling R-HSA-3928662
Adaptive Immune System R-HSA-1280218
RNA Polymerase II Transcription R-HSA-73857
EPHA-mediated growth cone collapse R-HSA-3928663
Leishmania infection R-HSA-9658195
Infectious disease R-HSA-5663205
Transcriptional regulation by RUNX2 R-HSA-8878166
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Regulation of KIT signaling R-HSA-1433559
Axon guidance R-HSA-422475
Developmental Biology R-HSA-1266738
Signaling by ERBB2 R-HSA-1227986
RUNX2 regulates bone development R-HSA-8941326
FCGR activation R-HSA-2029481
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Generic Transcription Pathway R-HSA-212436
Signaling by Interleukins R-HSA-449147
Disease R-HSA-1643685
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
EPH-ephrin mediated repulsion of cells R-HSA-3928665
CD28 co-stimulation R-HSA-389356
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Parasite infection R-HSA-9664407
Costimulation by the CD28 family R-HSA-388841
EPH-Ephrin signaling R-HSA-2682334
Innate Immune System R-HSA-168249

Expression Atlas ENSG00000176105
NCBI gene (formerly Entrezgene) 7525
GeneCards 12841
HGNC Symbol HGNC:12841
MIM gene 164880
UniProtKB Gene Name P07947
WikiGene 7525
Gene: RAF1
Ensembl ID : ENSG00000132155
Description: Raf-1 proto-oncogene, serine/threonine kinase
Gene Synonyms: C-RAF,CRAF,RAF-1
7 APIs:
224 Possible Orthologues:

Signaling downstream of RAS mutants R-HSA-9649948
CD209 (DC-SIGN) signaling R-HSA-5621575
RAF activation R-HSA-5673000
Signaling by RAS mutants R-HSA-6802949
Signaling by RAF1 mutants R-HSA-9656223
Platelet activation, signaling and aggregation R-HSA-76002
Oncogenic MAPK signaling R-HSA-6802957
Transport of small molecules R-HSA-382551
Signaling by MRAS-complex mutants R-HSA-9660537
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Innate Immune System R-HSA-168249
MAPK family signaling cascades R-HSA-5683057
Disease R-HSA-1643685
MAPK1/MAPK3 signaling R-HSA-5684996
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Stimuli-sensing channels R-HSA-2672351
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
RAF/MAP kinase cascade R-HSA-5673001
Negative feedback regulation of MAPK pathway R-HSA-5674499
Adaptive Immune System R-HSA-1280218
GP1b-IX-V activation signalling R-HSA-430116
Immune System R-HSA-168256
Ion channel transport R-HSA-983712
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
C-type lectin receptors (CLRs) R-HSA-5621481
Negative regulation of MAPK pathway R-HSA-5675221
Signal Transduction R-HSA-162582
MAP2K and MAPK activation R-HSA-5674135
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Hemostasis R-HSA-109582
Rap1 signalling R-HSA-392517
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Hemostasis R-HSA-109582
Negative feedback regulation of MAPK pathway R-HSA-5674499
CD209 (DC-SIGN) signaling R-HSA-5621575
MAP2K and MAPK activation R-HSA-5674135
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Negative regulation of MAPK pathway R-HSA-5675221
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Platelet activation, signaling and aggregation R-HSA-76002
Rap1 signalling R-HSA-392517
Signaling by RAF1 mutants R-HSA-9656223
Signaling by RAS mutants R-HSA-6802949
MAPK family signaling cascades R-HSA-5683057
Adaptive Immune System R-HSA-1280218
Signal Transduction R-HSA-162582
GP1b-IX-V activation signalling R-HSA-430116
Innate Immune System R-HSA-168249
Ion channel transport R-HSA-983712
Immune System R-HSA-168256
C-type lectin receptors (CLRs) R-HSA-5621481
Stimuli-sensing channels R-HSA-2672351
MAPK1/MAPK3 signaling R-HSA-5684996
Disease R-HSA-1643685
RAF/MAP kinase cascade R-HSA-5673001
Signaling by MRAS-complex mutants R-HSA-9660537
Transport of small molecules R-HSA-382551
Oncogenic MAPK signaling R-HSA-6802957
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
RAF activation R-HSA-5673000
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Signaling downstream of RAS mutants R-HSA-9649948
GP1b-IX-V activation signalling R-HSA-430116
Negative regulation of MAPK pathway R-HSA-5675221
Signaling by RAF1 mutants R-HSA-9656223
Immune System R-HSA-168256
Transport of small molecules R-HSA-382551
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Oncogenic MAPK signaling R-HSA-6802957
RAF activation R-HSA-5673000
MAPK family signaling cascades R-HSA-5683057
C-type lectin receptors (CLRs) R-HSA-5621481
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Ion channel transport R-HSA-983712
Platelet activation, signaling and aggregation R-HSA-76002
Negative feedback regulation of MAPK pathway R-HSA-5674499
Signaling by MRAS-complex mutants R-HSA-9660537
CD209 (DC-SIGN) signaling R-HSA-5621575
Signaling downstream of RAS mutants R-HSA-9649948
Stimuli-sensing channels R-HSA-2672351
Rap1 signalling R-HSA-392517
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Adaptive Immune System R-HSA-1280218
Signal Transduction R-HSA-162582
Innate Immune System R-HSA-168249
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
Disease R-HSA-1643685
RAF/MAP kinase cascade R-HSA-5673001
MAP2K and MAPK activation R-HSA-5674135
Signaling by RAS mutants R-HSA-6802949
Hemostasis R-HSA-109582
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
RAF activation R-HSA-5673000
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Negative regulation of MAPK pathway R-HSA-5675221
Negative feedback regulation of MAPK pathway R-HSA-5674499
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
MAPK family signaling cascades R-HSA-5683057
Signaling by RAS mutants R-HSA-6802949
Immune System R-HSA-168256
Signal Transduction R-HSA-162582
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Innate Immune System R-HSA-168249
GP1b-IX-V activation signalling R-HSA-430116
Oncogenic MAPK signaling R-HSA-6802957
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Platelet activation, signaling and aggregation R-HSA-76002
Adaptive Immune System R-HSA-1280218
Hemostasis R-HSA-109582
Rap1 signalling R-HSA-392517
MAP2K and MAPK activation R-HSA-5674135
Transport of small molecules R-HSA-382551
Signaling downstream of RAS mutants R-HSA-9649948
Stimuli-sensing channels R-HSA-2672351
C-type lectin receptors (CLRs) R-HSA-5621481
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
MAPK1/MAPK3 signaling R-HSA-5684996
CD209 (DC-SIGN) signaling R-HSA-5621575
RAF/MAP kinase cascade R-HSA-5673001
Signaling by MRAS-complex mutants R-HSA-9660537
Ion channel transport R-HSA-983712
Signaling by RAF1 mutants R-HSA-9656223
Disease R-HSA-1643685
MAPK1/MAPK3 signaling R-HSA-5684996
RAF activation R-HSA-5673000
MAP2K and MAPK activation R-HSA-5674135
Rap1 signalling R-HSA-392517
CD209 (DC-SIGN) signaling R-HSA-5621575
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Hemostasis R-HSA-109582
Ion channel transport R-HSA-983712
Negative regulation of MAPK pathway R-HSA-5675221
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Signaling downstream of RAS mutants R-HSA-9649948
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Transport of small molecules R-HSA-382551
Stimuli-sensing channels R-HSA-2672351
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Platelet activation, signaling and aggregation R-HSA-76002
RAF/MAP kinase cascade R-HSA-5673001
Oncogenic MAPK signaling R-HSA-6802957
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
Signaling by MRAS-complex mutants R-HSA-9660537
Adaptive Immune System R-HSA-1280218
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Innate Immune System R-HSA-168249
Signal Transduction R-HSA-162582
GP1b-IX-V activation signalling R-HSA-430116
Immune System R-HSA-168256
C-type lectin receptors (CLRs) R-HSA-5621481
Signaling by RAF1 mutants R-HSA-9656223
Negative feedback regulation of MAPK pathway R-HSA-5674499
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Disease R-HSA-1643685
Signaling by RAS mutants R-HSA-6802949
MAPK family signaling cascades R-HSA-5683057
RAF/MAP kinase cascade R-HSA-5673001
Negative feedback regulation of MAPK pathway R-HSA-5674499
Signaling by MRAS-complex mutants R-HSA-9660537
Oncogenic MAPK signaling R-HSA-6802957
RAF activation R-HSA-5673000
MAP2K and MAPK activation R-HSA-5674135
MAPK1/MAPK3 signaling R-HSA-5684996
Ion channel transport R-HSA-983712
GP1b-IX-V activation signalling R-HSA-430116
Negative regulation of MAPK pathway R-HSA-5675221
Platelet activation, signaling and aggregation R-HSA-76002
Stimuli-sensing channels R-HSA-2672351
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Rap1 signalling R-HSA-392517
Transport of small molecules R-HSA-382551
Signaling by RAS mutants R-HSA-6802949
Signaling downstream of RAS mutants R-HSA-9649948
MAPK family signaling cascades R-HSA-5683057
Disease R-HSA-1643685
Signal Transduction R-HSA-162582
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
C-type lectin receptors (CLRs) R-HSA-5621481
Immune System R-HSA-168256
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Adaptive Immune System R-HSA-1280218
CD209 (DC-SIGN) signaling R-HSA-5621575
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Signaling by RAF1 mutants R-HSA-9656223
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Hemostasis R-HSA-109582
Innate Immune System R-HSA-168249
Signaling by MRAS-complex mutants R-HSA-9660537
Signal Transduction R-HSA-162582
Negative feedback regulation of MAPK pathway R-HSA-5674499
Negative regulation of MAPK pathway R-HSA-5675221
GP1b-IX-V activation signalling R-HSA-430116
Immune System R-HSA-168256
RAF activation R-HSA-5673000
Adaptive Immune System R-HSA-1280218
MAPK1/MAPK3 signaling R-HSA-5684996
Disease R-HSA-1643685
Transport of small molecules R-HSA-382551
Stimuli-sensing channels R-HSA-2672351
CD209 (DC-SIGN) signaling R-HSA-5621575
Oncogenic MAPK signaling R-HSA-6802957
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Innate Immune System R-HSA-168249
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
MAPK family signaling cascades R-HSA-5683057
RAF/MAP kinase cascade R-HSA-5673001
Ion channel transport R-HSA-983712
MAP2K and MAPK activation R-HSA-5674135
Hemostasis R-HSA-109582
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Signaling by RAS mutants R-HSA-6802949
C-type lectin receptors (CLRs) R-HSA-5621481
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
Platelet activation, signaling and aggregation R-HSA-76002
Signaling by RAF1 mutants R-HSA-9656223
Rap1 signalling R-HSA-392517
Signaling downstream of RAS mutants R-HSA-9649948
Transport of small molecules R-HSA-382551
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Signaling by RAF1 mutants R-HSA-9656223
Immune System R-HSA-168256
Signaling downstream of RAS mutants R-HSA-9649948
Negative feedback regulation of MAPK pathway R-HSA-5674499
Platelet activation, signaling and aggregation R-HSA-76002
MAPK1/MAPK3 signaling R-HSA-5684996
Oncogenic MAPK signaling R-HSA-6802957
Signaling by MRAS-complex mutants R-HSA-9660537
RAF/MAP kinase cascade R-HSA-5673001
Innate Immune System R-HSA-168249
Signaling by BRAF and RAF1 fusions R-HSA-6802952
GP1b-IX-V activation signalling R-HSA-430116
Signal Transduction R-HSA-162582
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Hemostasis R-HSA-109582
MAPK family signaling cascades R-HSA-5683057
Ion channel transport R-HSA-983712
Stimuli-sensing channels R-HSA-2672351
Disease R-HSA-1643685
Signaling by RAS mutants R-HSA-6802949
Rap1 signalling R-HSA-392517
Negative regulation of MAPK pathway R-HSA-5675221
RAF activation R-HSA-5673000
CD209 (DC-SIGN) signaling R-HSA-5621575
C-type lectin receptors (CLRs) R-HSA-5621481
Adaptive Immune System R-HSA-1280218
MAP2K and MAPK activation R-HSA-5674135
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
Oncogenic MAPK signaling R-HSA-6802957
Innate Immune System R-HSA-168249
Signaling by RAF1 mutants R-HSA-9656223
MAPK family signaling cascades R-HSA-5683057
Transport of small molecules R-HSA-382551
Immune System R-HSA-168256
Signal Transduction R-HSA-162582
Adaptive Immune System R-HSA-1280218
C-type lectin receptors (CLRs) R-HSA-5621481
Rap1 signalling R-HSA-392517
Platelet activation, signaling and aggregation R-HSA-76002
Hemostasis R-HSA-109582
Signaling by MRAS-complex mutants R-HSA-9660537
Negative regulation of MAPK pathway R-HSA-5675221
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
Ion channel transport R-HSA-983712
Signaling by RAS mutants R-HSA-6802949
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Signaling by BRAF and RAF1 fusions R-HSA-6802952
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
GP1b-IX-V activation signalling R-HSA-430116
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
RAF/MAP kinase cascade R-HSA-5673001
Stimuli-sensing channels R-HSA-2672351
Signaling downstream of RAS mutants R-HSA-9649948
CD209 (DC-SIGN) signaling R-HSA-5621575
RAF activation R-HSA-5673000
Negative feedback regulation of MAPK pathway R-HSA-5674499
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Disease R-HSA-1643685
MAPK1/MAPK3 signaling R-HSA-5684996
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
MAP2K and MAPK activation R-HSA-5674135
Signaling by BRAF and RAF1 fusions R-HSA-6802952
C-type lectin receptors (CLRs) R-HSA-5621481
Adaptive Immune System R-HSA-1280218
Signaling by RAF1 mutants R-HSA-9656223
Oncogenic MAPK signaling R-HSA-6802957
Rap1 signalling R-HSA-392517
CD209 (DC-SIGN) signaling R-HSA-5621575
Signaling by RAS mutants R-HSA-6802949
MAPK1/MAPK3 signaling R-HSA-5684996
Platelet activation, signaling and aggregation R-HSA-76002
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Innate Immune System R-HSA-168249
Stimuli-sensing channels R-HSA-2672351
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842
Disease R-HSA-1643685
Signal Transduction R-HSA-162582
Ion channel transport R-HSA-983712
Signaling downstream of RAS mutants R-HSA-9649948
MAPK family signaling cascades R-HSA-5683057
Negative regulation of MAPK pathway R-HSA-5675221
Transport of small molecules R-HSA-382551
Immune System R-HSA-168256
GP1b-IX-V activation signalling R-HSA-430116
RAF/MAP kinase cascade R-HSA-5673001
Signaling by high-kinase activity BRAF mutants R-HSA-6802948
MAP2K and MAPK activation R-HSA-5674135
Signaling by MRAS-complex mutants R-HSA-9660537
Hemostasis R-HSA-109582
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946
Negative feedback regulation of MAPK pathway R-HSA-5674499
RAF activation R-HSA-5673000

Expression Atlas ENSG00000132155
LRG display in Ensembl gene LRG_413
NCBI gene (formerly Entrezgene) 5894
GeneCards 9829
HGNC Symbol HGNC:9829
MIM gene 164760
MIM morbid 615916
UniProtKB Gene Name P04049
WikiGene 5894
Gene: FLT3
Ensembl ID : ENSG00000122025
Description: fms related receptor tyrosine kinase 3
Gene Synonyms: CD135,FLK2,STK1
41 APIs:
134 Possible Orthologues:

tamatinib-resistant FLT3 mutants R-HSA-9703009
Immune System R-HSA-168256
STAT5 Activation R-HSA-9645135
Insulin receptor signalling cascade R-HSA-74751
gilteritinib-resistant FLT3 mutants R-HSA-9702590
IRS-related events triggered by IGF1R R-HSA-2428928
IRS-mediated signalling R-HSA-112399
FLT3 Signaling R-HSA-9607240
quizartinib-resistant FLT3 mutants R-HSA-9702620
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by Insulin receptor R-HSA-74752
ponatinib-resistant FLT3 mutants R-HSA-9702614
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
crenolanib-resistant FLT3 mutants R-HSA-9702581
Negative regulation of the PI3K/AKT network R-HSA-199418
FLT3 signaling by CBL mutants R-HSA-9706377
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
sorafenib-resistant FLT3 mutants R-HSA-9702624
Drug resistance of FLT3 mutants R-HSA-9702506
linifanib-resistant FLT3 mutants R-HSA-9702998
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
tamatinib-resistant FLT3 mutants R-HSA-9703009
PI3K/AKT Signaling in Cancer R-HSA-2219528
semaxanib-resistant FLT3 mutants R-HSA-9702577
sunitinib-resistant FLT3 mutants R-HSA-9702632
Disease R-HSA-1643685
FLT3 mutants bind TKIs R-HSA-9702509
FLT3 signaling through SRC family kinases R-HSA-9706374
FLT3 signaling in disease R-HSA-9682385
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
IGF1R signaling cascade R-HSA-2428924
pexidartinib-resistant FLT3 mutants R-HSA-9702605
Signal Transduction R-HSA-162582
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
KW2449-resistant FLT3 mutants R-HSA-9702569
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
RAF/MAP kinase cascade R-HSA-5673001
PIP3 activates AKT signaling R-HSA-1257604
Intracellular signaling by second messengers R-HSA-9006925
tandutinib-resistant FLT3 mutants R-HSA-9702636
Cytokine Signaling in Immune system R-HSA-1280215
MAPK family signaling cascades R-HSA-5683057
Negative regulation of FLT3 R-HSA-9706369
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
midostaurin-resistant FLT3 mutants R-HSA-9702600
PI3K Cascade R-HSA-109704
MAPK1/MAPK3 signaling R-HSA-5684996
Insulin receptor signalling cascade R-HSA-74751
linifanib-resistant FLT3 mutants R-HSA-9702998
PIP3 activates AKT signaling R-HSA-1257604
quizartinib-resistant FLT3 mutants R-HSA-9702620
tamatinib-resistant FLT3 mutants R-HSA-9703009
tandutinib-resistant FLT3 mutants R-HSA-9702636
PI3K/AKT Signaling in Cancer R-HSA-2219528
Immune System R-HSA-168256
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Signal Transduction R-HSA-162582
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
IRS-related events triggered by IGF1R R-HSA-2428928
KW2449-resistant FLT3 mutants R-HSA-9702569
MAPK family signaling cascades R-HSA-5683057
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
FLT3 mutants bind TKIs R-HSA-9702509
PI3K Cascade R-HSA-109704
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Insulin receptor R-HSA-74752
IRS-mediated signalling R-HSA-112399
gilteritinib-resistant FLT3 mutants R-HSA-9702590
IGF1R signaling cascade R-HSA-2428924
sunitinib-resistant FLT3 mutants R-HSA-9702632
Negative regulation of FLT3 R-HSA-9706369
FLT3 Signaling R-HSA-9607240
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Drug resistance of FLT3 mutants R-HSA-9702506
FLT3 signaling by CBL mutants R-HSA-9706377
RAF/MAP kinase cascade R-HSA-5673001
Negative regulation of the PI3K/AKT network R-HSA-199418
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Disease R-HSA-1643685
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
FLT3 signaling in disease R-HSA-9682385
sorafenib-resistant FLT3 mutants R-HSA-9702624
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
pexidartinib-resistant FLT3 mutants R-HSA-9702605
crenolanib-resistant FLT3 mutants R-HSA-9702581
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Intracellular signaling by second messengers R-HSA-9006925
FLT3 signaling through SRC family kinases R-HSA-9706374
STAT5 Activation R-HSA-9645135
MAPK1/MAPK3 signaling R-HSA-5684996
midostaurin-resistant FLT3 mutants R-HSA-9702600
semaxanib-resistant FLT3 mutants R-HSA-9702577
ponatinib-resistant FLT3 mutants R-HSA-9702614
FLT3 signaling by CBL mutants R-HSA-9706377
Cytokine Signaling in Immune system R-HSA-1280215
IRS-mediated signalling R-HSA-112399
FLT3 signaling in disease R-HSA-9682385
gilteritinib-resistant FLT3 mutants R-HSA-9702590
FLT3 signaling through SRC family kinases R-HSA-9706374
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signal Transduction R-HSA-162582
PI3K/AKT Signaling in Cancer R-HSA-2219528
midostaurin-resistant FLT3 mutants R-HSA-9702600
IRS-related events triggered by IGF1R R-HSA-2428928
ponatinib-resistant FLT3 mutants R-HSA-9702614
Insulin receptor signalling cascade R-HSA-74751
FLT3 mutants bind TKIs R-HSA-9702509
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
crenolanib-resistant FLT3 mutants R-HSA-9702581
IGF1R signaling cascade R-HSA-2428924
RAF/MAP kinase cascade R-HSA-5673001
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
sorafenib-resistant FLT3 mutants R-HSA-9702624
Negative regulation of the PI3K/AKT network R-HSA-199418
Intracellular signaling by second messengers R-HSA-9006925
Signaling by Insulin receptor R-HSA-74752
Immune System R-HSA-168256
linifanib-resistant FLT3 mutants R-HSA-9702998
FLT3 Signaling R-HSA-9607240
sunitinib-resistant FLT3 mutants R-HSA-9702632
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
PI3K Cascade R-HSA-109704
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
MAPK family signaling cascades R-HSA-5683057
pexidartinib-resistant FLT3 mutants R-HSA-9702605
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Disease R-HSA-1643685
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
STAT5 Activation R-HSA-9645135
KW2449-resistant FLT3 mutants R-HSA-9702569
Negative regulation of FLT3 R-HSA-9706369
Drug resistance of FLT3 mutants R-HSA-9702506
PIP3 activates AKT signaling R-HSA-1257604
quizartinib-resistant FLT3 mutants R-HSA-9702620
tandutinib-resistant FLT3 mutants R-HSA-9702636
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
tamatinib-resistant FLT3 mutants R-HSA-9703009
semaxanib-resistant FLT3 mutants R-HSA-9702577
crenolanib-resistant FLT3 mutants R-HSA-9702581
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
RAF/MAP kinase cascade R-HSA-5673001
FLT3 Signaling R-HSA-9607240
linifanib-resistant FLT3 mutants R-HSA-9702998
Negative regulation of FLT3 R-HSA-9706369
gilteritinib-resistant FLT3 mutants R-HSA-9702590
MAPK1/MAPK3 signaling R-HSA-5684996
KW2449-resistant FLT3 mutants R-HSA-9702569
ponatinib-resistant FLT3 mutants R-HSA-9702614
FLT3 mutants bind TKIs R-HSA-9702509
IRS-related events triggered by IGF1R R-HSA-2428928
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Drug resistance of FLT3 mutants R-HSA-9702506
FLT3 signaling through SRC family kinases R-HSA-9706374
midostaurin-resistant FLT3 mutants R-HSA-9702600
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Immune System R-HSA-168256
quizartinib-resistant FLT3 mutants R-HSA-9702620
Intracellular signaling by second messengers R-HSA-9006925
semaxanib-resistant FLT3 mutants R-HSA-9702577
PIP3 activates AKT signaling R-HSA-1257604
sorafenib-resistant FLT3 mutants R-HSA-9702624
FLT3 signaling in disease R-HSA-9682385
STAT5 Activation R-HSA-9645135
Cytokine Signaling in Immune system R-HSA-1280215
Signal Transduction R-HSA-162582
tandutinib-resistant FLT3 mutants R-HSA-9702636
sunitinib-resistant FLT3 mutants R-HSA-9702632
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
IRS-mediated signalling R-HSA-112399
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by Insulin receptor R-HSA-74752
IGF1R signaling cascade R-HSA-2428924
PI3K Cascade R-HSA-109704
MAPK family signaling cascades R-HSA-5683057
Insulin receptor signalling cascade R-HSA-74751
tamatinib-resistant FLT3 mutants R-HSA-9703009
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
PI3K/AKT Signaling in Cancer R-HSA-2219528
FLT3 signaling by CBL mutants R-HSA-9706377
pexidartinib-resistant FLT3 mutants R-HSA-9702605
Disease R-HSA-1643685
Negative regulation of the PI3K/AKT network R-HSA-199418
quizartinib-resistant FLT3 mutants R-HSA-9702620
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI3K/AKT Signaling in Cancer R-HSA-2219528
IRS-mediated signalling R-HSA-112399
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
IRS-related events triggered by IGF1R R-HSA-2428928
sorafenib-resistant FLT3 mutants R-HSA-9702624
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signal Transduction R-HSA-162582
FLT3 Signaling R-HSA-9607240
Cytokine Signaling in Immune system R-HSA-1280215
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
crenolanib-resistant FLT3 mutants R-HSA-9702581
Insulin receptor signalling cascade R-HSA-74751
Negative regulation of the PI3K/AKT network R-HSA-199418
pexidartinib-resistant FLT3 mutants R-HSA-9702605
tamatinib-resistant FLT3 mutants R-HSA-9703009
Negative regulation of FLT3 R-HSA-9706369
MAPK1/MAPK3 signaling R-HSA-5684996
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
FLT3 signaling in disease R-HSA-9682385
gilteritinib-resistant FLT3 mutants R-HSA-9702590
PI3K Cascade R-HSA-109704
Disease R-HSA-1643685
KW2449-resistant FLT3 mutants R-HSA-9702569
MAPK family signaling cascades R-HSA-5683057
ponatinib-resistant FLT3 mutants R-HSA-9702614
Immune System R-HSA-168256
midostaurin-resistant FLT3 mutants R-HSA-9702600
semaxanib-resistant FLT3 mutants R-HSA-9702577
STAT5 Activation R-HSA-9645135
PIP3 activates AKT signaling R-HSA-1257604
Drug resistance of FLT3 mutants R-HSA-9702506
Signaling by Insulin receptor R-HSA-74752
IGF1R signaling cascade R-HSA-2428924
linifanib-resistant FLT3 mutants R-HSA-9702998
FLT3 signaling by CBL mutants R-HSA-9706377
tandutinib-resistant FLT3 mutants R-HSA-9702636
sunitinib-resistant FLT3 mutants R-HSA-9702632
RAF/MAP kinase cascade R-HSA-5673001
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
FLT3 mutants bind TKIs R-HSA-9702509
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Intracellular signaling by second messengers R-HSA-9006925
FLT3 signaling through SRC family kinases R-HSA-9706374
Drug resistance of FLT3 mutants R-HSA-9702506
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
IRS-related events triggered by IGF1R R-HSA-2428928
FLT3 signaling by CBL mutants R-HSA-9706377
pexidartinib-resistant FLT3 mutants R-HSA-9702605
sorafenib-resistant FLT3 mutants R-HSA-9702624
gilteritinib-resistant FLT3 mutants R-HSA-9702590
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
linifanib-resistant FLT3 mutants R-HSA-9702998
FLT3 signaling through SRC family kinases R-HSA-9706374
quizartinib-resistant FLT3 mutants R-HSA-9702620
RAF/MAP kinase cascade R-HSA-5673001
Intracellular signaling by second messengers R-HSA-9006925
sunitinib-resistant FLT3 mutants R-HSA-9702632
MAPK family signaling cascades R-HSA-5683057
IGF1R signaling cascade R-HSA-2428924
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Negative regulation of FLT3 R-HSA-9706369
Signal Transduction R-HSA-162582
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
crenolanib-resistant FLT3 mutants R-HSA-9702581
PI3K/AKT Signaling in Cancer R-HSA-2219528
Insulin receptor signalling cascade R-HSA-74751
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Immune System R-HSA-168256
FLT3 mutants bind TKIs R-HSA-9702509
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Insulin receptor R-HSA-74752
semaxanib-resistant FLT3 mutants R-HSA-9702577
tandutinib-resistant FLT3 mutants R-HSA-9702636
Negative regulation of the PI3K/AKT network R-HSA-199418
Cytokine Signaling in Immune system R-HSA-1280215
tamatinib-resistant FLT3 mutants R-HSA-9703009
FLT3 signaling in disease R-HSA-9682385
KW2449-resistant FLT3 mutants R-HSA-9702569
midostaurin-resistant FLT3 mutants R-HSA-9702600
ponatinib-resistant FLT3 mutants R-HSA-9702614
Disease R-HSA-1643685
PIP3 activates AKT signaling R-HSA-1257604
STAT5 Activation R-HSA-9645135
FLT3 Signaling R-HSA-9607240
IRS-mediated signalling R-HSA-112399
PI3K Cascade R-HSA-109704
crenolanib-resistant FLT3 mutants R-HSA-9702581
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signal Transduction R-HSA-162582
STAT5 Activation R-HSA-9645135
tandutinib-resistant FLT3 mutants R-HSA-9702636
Signaling by Insulin receptor R-HSA-74752
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
MAPK family signaling cascades R-HSA-5683057
Cytokine Signaling in Immune system R-HSA-1280215
IGF1R signaling cascade R-HSA-2428924
Drug resistance of FLT3 mutants R-HSA-9702506
RAF/MAP kinase cascade R-HSA-5673001
PI3K/AKT Signaling in Cancer R-HSA-2219528
IRS-related events triggered by IGF1R R-HSA-2428928
Intracellular signaling by second messengers R-HSA-9006925
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Insulin receptor signalling cascade R-HSA-74751
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
FLT3 signaling through SRC family kinases R-HSA-9706374
sorafenib-resistant FLT3 mutants R-HSA-9702624
gilteritinib-resistant FLT3 mutants R-HSA-9702590
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
IRS-mediated signalling R-HSA-112399
MAPK1/MAPK3 signaling R-HSA-5684996
PI3K Cascade R-HSA-109704
FLT3 signaling by CBL mutants R-HSA-9706377
Negative regulation of the PI3K/AKT network R-HSA-199418
KW2449-resistant FLT3 mutants R-HSA-9702569
linifanib-resistant FLT3 mutants R-HSA-9702998
semaxanib-resistant FLT3 mutants R-HSA-9702577
FLT3 signaling in disease R-HSA-9682385
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
pexidartinib-resistant FLT3 mutants R-HSA-9702605
tamatinib-resistant FLT3 mutants R-HSA-9703009
sunitinib-resistant FLT3 mutants R-HSA-9702632
FLT3 Signaling R-HSA-9607240
FLT3 mutants bind TKIs R-HSA-9702509
Disease R-HSA-1643685
Negative regulation of FLT3 R-HSA-9706369
quizartinib-resistant FLT3 mutants R-HSA-9702620
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
ponatinib-resistant FLT3 mutants R-HSA-9702614
PIP3 activates AKT signaling R-HSA-1257604
midostaurin-resistant FLT3 mutants R-HSA-9702600
Immune System R-HSA-168256
crenolanib-resistant FLT3 mutants R-HSA-9702581
FLT3 signaling through SRC family kinases R-HSA-9706374
Signaling by Insulin receptor R-HSA-74752
tandutinib-resistant FLT3 mutants R-HSA-9702636
IRS-related events triggered by IGF1R R-HSA-2428928
quizartinib-resistant FLT3 mutants R-HSA-9702620
MAPK family signaling cascades R-HSA-5683057
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
FLT3 signaling in disease R-HSA-9682385
PI3K Cascade R-HSA-109704
IRS-mediated signalling R-HSA-112399
sunitinib-resistant FLT3 mutants R-HSA-9702632
Intracellular signaling by second messengers R-HSA-9006925
FLT3 mutants bind TKIs R-HSA-9702509
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
gilteritinib-resistant FLT3 mutants R-HSA-9702590
Signal Transduction R-HSA-162582
PIP3 activates AKT signaling R-HSA-1257604
Negative regulation of the PI3K/AKT network R-HSA-199418
FLT3 Signaling R-HSA-9607240
KW2449-resistant FLT3 mutants R-HSA-9702569
RAF/MAP kinase cascade R-HSA-5673001
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
linifanib-resistant FLT3 mutants R-HSA-9702998
Drug resistance of FLT3 mutants R-HSA-9702506
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
Immune System R-HSA-168256
sorafenib-resistant FLT3 mutants R-HSA-9702624
Cytokine Signaling in Immune system R-HSA-1280215
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
semaxanib-resistant FLT3 mutants R-HSA-9702577
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
midostaurin-resistant FLT3 mutants R-HSA-9702600
MAPK1/MAPK3 signaling R-HSA-5684996
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
pexidartinib-resistant FLT3 mutants R-HSA-9702605
ponatinib-resistant FLT3 mutants R-HSA-9702614
FLT3 signaling by CBL mutants R-HSA-9706377
STAT5 Activation R-HSA-9645135
Negative regulation of FLT3 R-HSA-9706369
Disease R-HSA-1643685
Insulin receptor signalling cascade R-HSA-74751
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
IGF1R signaling cascade R-HSA-2428924
Drug resistance of FLT3 mutants R-HSA-9702506
FLT3 signaling by CBL mutants R-HSA-9706377
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
FLT3 Signaling R-HSA-9607240
FLT3 mutants bind TKIs R-HSA-9702509
Negative regulation of the PI3K/AKT network R-HSA-199418
tandutinib-resistant FLT3 mutants R-HSA-9702636
Cytokine Signaling in Immune system R-HSA-1280215
Intracellular signaling by second messengers R-HSA-9006925
gilteritinib-resistant FLT3 mutants R-HSA-9702590
tamatinib-resistant FLT3 mutants R-HSA-9703009
crenolanib-resistant FLT3 mutants R-HSA-9702581
Immune System R-HSA-168256
FLT3 signaling in disease R-HSA-9682385
linifanib-resistant FLT3 mutants R-HSA-9702998
Disease R-HSA-1643685
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
PIP3 activates AKT signaling R-HSA-1257604
FLT3 signaling through SRC family kinases R-HSA-9706374
Negative regulation of FLT3 R-HSA-9706369
midostaurin-resistant FLT3 mutants R-HSA-9702600
PI3K Cascade R-HSA-109704
sunitinib-resistant FLT3 mutants R-HSA-9702632
STAT5 Activation R-HSA-9645135
RAF/MAP kinase cascade R-HSA-5673001
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Signaling by Insulin receptor R-HSA-74752
MAPK1/MAPK3 signaling R-HSA-5684996
quizartinib-resistant FLT3 mutants R-HSA-9702620
ponatinib-resistant FLT3 mutants R-HSA-9702614
IRS-related events triggered by IGF1R R-HSA-2428928
Signal Transduction R-HSA-162582
sorafenib-resistant FLT3 mutants R-HSA-9702624
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
pexidartinib-resistant FLT3 mutants R-HSA-9702605
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
semaxanib-resistant FLT3 mutants R-HSA-9702577
IGF1R signaling cascade R-HSA-2428924
MAPK family signaling cascades R-HSA-5683057
KW2449-resistant FLT3 mutants R-HSA-9702569
IRS-mediated signalling R-HSA-112399
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
PI3K/AKT Signaling in Cancer R-HSA-2219528
lestaurtinib-resistant FLT3 mutants R-HSA-9702596
Insulin receptor signalling cascade R-HSA-74751
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by Insulin receptor R-HSA-74752
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648
midostaurin-resistant FLT3 mutants R-HSA-9702600
FLT3 signaling through SRC family kinases R-HSA-9706374
FLT3 Signaling R-HSA-9607240
Immune System R-HSA-168256
Intracellular signaling by second messengers R-HSA-9006925
PI3K/AKT Signaling in Cancer R-HSA-2219528
Negative regulation of FLT3 R-HSA-9706369
Drug resistance of FLT3 mutants R-HSA-9702506
sorafenib-resistant FLT3 mutants R-HSA-9702624
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
IRS-related events triggered by IGF1R R-HSA-2428928
FLT3 mutants bind TKIs R-HSA-9702509
IRS-mediated signalling R-HSA-112399
pexidartinib-resistant FLT3 mutants R-HSA-9702605
MAPK1/MAPK3 signaling R-HSA-5684996
RAF/MAP kinase cascade R-HSA-5673001
quizartinib-resistant FLT3 mutants R-HSA-9702620
semaxanib-resistant FLT3 mutants R-HSA-9702577
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
gilteritinib-resistant FLT3 mutants R-HSA-9702590
MAPK family signaling cascades R-HSA-5683057
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518
Negative regulation of the PI3K/AKT network R-HSA-199418
Cytokine Signaling in Immune system R-HSA-1280215
FLT3 signaling by CBL mutants R-HSA-9706377
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
sunitinib-resistant FLT3 mutants R-HSA-9702632
STAT5 Activation R-HSA-9645135
tamatinib-resistant FLT3 mutants R-HSA-9703009
IGF1R signaling cascade R-HSA-2428924
Insulin receptor signalling cascade R-HSA-74751
ponatinib-resistant FLT3 mutants R-HSA-9702614
Signal Transduction R-HSA-162582
PI3K Cascade R-HSA-109704
linifanib-resistant FLT3 mutants R-HSA-9702998
tandutinib-resistant FLT3 mutants R-HSA-9702636
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
PIP3 activates AKT signaling R-HSA-1257604
KW2449-resistant FLT3 mutants R-HSA-9702569
FLT3 signaling in disease R-HSA-9682385
crenolanib-resistant FLT3 mutants R-HSA-9702581
Disease R-HSA-1643685
lestaurtinib-resistant FLT3 mutants R-HSA-9702596

Expression Atlas ENSG00000122025
LRG display in Ensembl gene LRG_457
NCBI gene (formerly Entrezgene) 2322
GeneCards 3765
HGNC Symbol HGNC:3765
MIM gene 136351
MIM morbid 613065
UniProtKB Gene Name P36888
WikiGene 2322
Gene: PRKCG
Ensembl ID : ENSG00000126583
Description: protein kinase C gamma
Gene Synonyms: MGC57564,PKCC,PKCG,SCA14
5 APIs:
200 Possible Orthologues:

G alpha (i) signalling events R-HSA-418594
DAG and IP3 signaling R-HSA-1489509
Transmission across Chemical Synapses R-HSA-112315
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
PLC beta mediated events R-HSA-112043
G alpha (z) signalling events R-HSA-418597
Beta-catenin independent WNT signaling R-HSA-3858494
CaM pathway R-HSA-111997
Signaling by WNT R-HSA-195721
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Trafficking of AMPA receptors R-HSA-399719
Intracellular signaling by second messengers R-HSA-9006925
Neuronal System R-HSA-112316
Platelet activation, signaling and aggregation R-HSA-76002
Disinhibition of SNARE formation R-HSA-114516
PCP/CE pathway R-HSA-4086400
Signaling by GPCR R-HSA-372790
G alpha (i) signalling events R-HSA-418594
Calmodulin induced events R-HSA-111933
GPCR downstream signalling R-HSA-388396
Hemostasis R-HSA-109582
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Opioid Signalling R-HSA-111885
Ca-dependent events R-HSA-111996
Signal Transduction R-HSA-162582
WNT5A-dependent internalization of FZD4 R-HSA-5099900
G-protein mediated events R-HSA-112040
Hemostasis R-HSA-109582
PLC beta mediated events R-HSA-112043
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Opioid Signalling R-HSA-111885
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
GPCR downstream signalling R-HSA-388396
PCP/CE pathway R-HSA-4086400
G-protein mediated events R-HSA-112040
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Transmission across Chemical Synapses R-HSA-112315
Neuronal System R-HSA-112316
G alpha (i) signalling events R-HSA-418594
Platelet activation, signaling and aggregation R-HSA-76002
G alpha (z) signalling events R-HSA-418597
Signaling by WNT R-HSA-195721
Calmodulin induced events R-HSA-111933
Intracellular signaling by second messengers R-HSA-9006925
Ca-dependent events R-HSA-111996
Signal Transduction R-HSA-162582
Trafficking of AMPA receptors R-HSA-399719
Beta-catenin independent WNT signaling R-HSA-3858494
Signaling by GPCR R-HSA-372790
CaM pathway R-HSA-111997
Disinhibition of SNARE formation R-HSA-114516
DAG and IP3 signaling R-HSA-1489509
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
G alpha (i) signalling events R-HSA-418594
PCP/CE pathway R-HSA-4086400
PLC beta mediated events R-HSA-112043
Transmission across Chemical Synapses R-HSA-112315
Neuronal System R-HSA-112316
Signaling by WNT R-HSA-195721
Ca-dependent events R-HSA-111996
DAG and IP3 signaling R-HSA-1489509
G-protein mediated events R-HSA-112040
Hemostasis R-HSA-109582
Intracellular signaling by second messengers R-HSA-9006925
WNT5A-dependent internalization of FZD4 R-HSA-5099900
G alpha (z) signalling events R-HSA-418597
Opioid Signalling R-HSA-111885
Beta-catenin independent WNT signaling R-HSA-3858494
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Calmodulin induced events R-HSA-111933
Signal Transduction R-HSA-162582
Platelet activation, signaling and aggregation R-HSA-76002
Disinhibition of SNARE formation R-HSA-114516
CaM pathway R-HSA-111997
Trafficking of AMPA receptors R-HSA-399719
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Signaling by GPCR R-HSA-372790
GPCR downstream signalling R-HSA-388396
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Neuronal System R-HSA-112316
Beta-catenin independent WNT signaling R-HSA-3858494
DAG and IP3 signaling R-HSA-1489509
Calmodulin induced events R-HSA-111933
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Intracellular signaling by second messengers R-HSA-9006925
Trafficking of AMPA receptors R-HSA-399719
Signal Transduction R-HSA-162582
Ca-dependent events R-HSA-111996
Hemostasis R-HSA-109582
Platelet activation, signaling and aggregation R-HSA-76002
Signaling by WNT R-HSA-195721
G-protein mediated events R-HSA-112040
Signaling by GPCR R-HSA-372790
PCP/CE pathway R-HSA-4086400
PLC beta mediated events R-HSA-112043
G alpha (i) signalling events R-HSA-418594
G alpha (z) signalling events R-HSA-418597
GPCR downstream signalling R-HSA-388396
Opioid Signalling R-HSA-111885
Transmission across Chemical Synapses R-HSA-112315
CaM pathway R-HSA-111997
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Disinhibition of SNARE formation R-HSA-114516
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
DAG and IP3 signaling R-HSA-1489509
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Signaling by WNT R-HSA-195721
PLC beta mediated events R-HSA-112043
Intracellular signaling by second messengers R-HSA-9006925
G-protein mediated events R-HSA-112040
PCP/CE pathway R-HSA-4086400
Neuronal System R-HSA-112316
Signal Transduction R-HSA-162582
Ca-dependent events R-HSA-111996
GPCR downstream signalling R-HSA-388396
Hemostasis R-HSA-109582
Calmodulin induced events R-HSA-111933
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Disinhibition of SNARE formation R-HSA-114516
G alpha (z) signalling events R-HSA-418597
CaM pathway R-HSA-111997
Transmission across Chemical Synapses R-HSA-112315
Signaling by GPCR R-HSA-372790
Beta-catenin independent WNT signaling R-HSA-3858494
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Platelet activation, signaling and aggregation R-HSA-76002
Trafficking of AMPA receptors R-HSA-399719
Opioid Signalling R-HSA-111885
Beta-catenin independent WNT signaling R-HSA-3858494
G alpha (i) signalling events R-HSA-418594
Hemostasis R-HSA-109582
WNT5A-dependent internalization of FZD4 R-HSA-5099900
G-protein mediated events R-HSA-112040
Trafficking of AMPA receptors R-HSA-399719
PCP/CE pathway R-HSA-4086400
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Calmodulin induced events R-HSA-111933
GPCR downstream signalling R-HSA-388396
Disinhibition of SNARE formation R-HSA-114516
DAG and IP3 signaling R-HSA-1489509
Transmission across Chemical Synapses R-HSA-112315
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Neuronal System R-HSA-112316
Ca-dependent events R-HSA-111996
G alpha (z) signalling events R-HSA-418597
Opioid Signalling R-HSA-111885
PLC beta mediated events R-HSA-112043
Intracellular signaling by second messengers R-HSA-9006925
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
Signaling by WNT R-HSA-195721
Platelet activation, signaling and aggregation R-HSA-76002
CaM pathway R-HSA-111997
Signaling by GPCR R-HSA-372790
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Signal Transduction R-HSA-162582
Beta-catenin independent WNT signaling R-HSA-3858494
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
GPCR downstream signalling R-HSA-388396
DAG and IP3 signaling R-HSA-1489509
Trafficking of AMPA receptors R-HSA-399719
Ca-dependent events R-HSA-111996
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Signaling by GPCR R-HSA-372790
CaM pathway R-HSA-111997
Signaling by WNT R-HSA-195721
Calmodulin induced events R-HSA-111933
PLC beta mediated events R-HSA-112043
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Neuronal System R-HSA-112316
Signal Transduction R-HSA-162582
G alpha (i) signalling events R-HSA-418594
Platelet activation, signaling and aggregation R-HSA-76002
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Transmission across Chemical Synapses R-HSA-112315
Opioid Signalling R-HSA-111885
Disinhibition of SNARE formation R-HSA-114516
G alpha (z) signalling events R-HSA-418597
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
PCP/CE pathway R-HSA-4086400
Intracellular signaling by second messengers R-HSA-9006925
G-protein mediated events R-HSA-112040
Hemostasis R-HSA-109582
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Hemostasis R-HSA-109582
CaM pathway R-HSA-111997
Trafficking of AMPA receptors R-HSA-399719
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Transmission across Chemical Synapses R-HSA-112315
Signaling by WNT R-HSA-195721
GPCR downstream signalling R-HSA-388396
Signaling by GPCR R-HSA-372790
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
PCP/CE pathway R-HSA-4086400
Beta-catenin independent WNT signaling R-HSA-3858494
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Disinhibition of SNARE formation R-HSA-114516
G alpha (z) signalling events R-HSA-418597
DAG and IP3 signaling R-HSA-1489509
Platelet activation, signaling and aggregation R-HSA-76002
Neuronal System R-HSA-112316
Calmodulin induced events R-HSA-111933
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Opioid Signalling R-HSA-111885
Ca-dependent events R-HSA-111996
G alpha (i) signalling events R-HSA-418594
Signal Transduction R-HSA-162582
PLC beta mediated events R-HSA-112043
G-protein mediated events R-HSA-112040
Intracellular signaling by second messengers R-HSA-9006925
Signal Transduction R-HSA-162582
Platelet activation, signaling and aggregation R-HSA-76002
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
CaM pathway R-HSA-111997
PLC beta mediated events R-HSA-112043
Beta-catenin independent WNT signaling R-HSA-3858494
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
Opioid Signalling R-HSA-111885
Intracellular signaling by second messengers R-HSA-9006925
Trafficking of AMPA receptors R-HSA-399719
G alpha (i) signalling events R-HSA-418594
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
G-protein mediated events R-HSA-112040
Disinhibition of SNARE formation R-HSA-114516
PCP/CE pathway R-HSA-4086400
Neuronal System R-HSA-112316
Hemostasis R-HSA-109582
GPCR downstream signalling R-HSA-388396
Transmission across Chemical Synapses R-HSA-112315
Signaling by GPCR R-HSA-372790
Ca-dependent events R-HSA-111996
G alpha (z) signalling events R-HSA-418597
DAG and IP3 signaling R-HSA-1489509
Signaling by WNT R-HSA-195721
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Calmodulin induced events R-HSA-111933
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Disinhibition of SNARE formation R-HSA-114516
Opioid Signalling R-HSA-111885
Signal Transduction R-HSA-162582
WNT5A-dependent internalization of FZD4 R-HSA-5099900
Beta-catenin independent WNT signaling R-HSA-3858494
Intracellular signaling by second messengers R-HSA-9006925
Ca-dependent events R-HSA-111996
Calmodulin induced events R-HSA-111933
Signaling by GPCR R-HSA-372790
G-protein mediated events R-HSA-112040
Response to elevated platelet cytosolic Ca2+ R-HSA-76005
DAG and IP3 signaling R-HSA-1489509
Neuronal System R-HSA-112316
G alpha (z) signalling events R-HSA-418597
PCP/CE pathway R-HSA-4086400
Trafficking of GluR2-containing AMPA receptors R-HSA-416993
Platelet activation, signaling and aggregation R-HSA-76002
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314
Signaling by WNT R-HSA-195721
CaM pathway R-HSA-111997
G alpha (i) signalling events R-HSA-418594
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721
PLC beta mediated events R-HSA-112043
Trafficking of AMPA receptors R-HSA-399719
GPCR downstream signalling R-HSA-388396
Hemostasis R-HSA-109582
Transmission across Chemical Synapses R-HSA-112315

Expression Atlas ENSG00000126583
LRG display in Ensembl gene LRG_669
NCBI gene (formerly Entrezgene) 5582
GeneCards 9402
HGNC Symbol HGNC:9402
MIM gene 176980
MIM morbid 605361
UniProtKB Gene Name P05129
WikiGene 5582
Gene: ACVRL1
Ensembl ID : ENSG00000139567
Description: activin A receptor like type 1
Gene Synonyms: ACVRLK1,ALK1,HHT,HHT2,ORW2
2 APIs:
358 Possible Orthologues:

Signal Transduction R-HSA-162582
Signaling by BMP R-HSA-201451
Signaling by TGFB family members R-HSA-9006936
Signal Transduction R-HSA-162582
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signaling by TGFB family members R-HSA-9006936
Signal Transduction R-HSA-162582
Signaling by BMP R-HSA-201451
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signal Transduction R-HSA-162582
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signal Transduction R-HSA-162582
Signal Transduction R-HSA-162582
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signal Transduction R-HSA-162582
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signaling by TGFB family members R-HSA-9006936
Signaling by BMP R-HSA-201451
Signal Transduction R-HSA-162582

Expression Atlas ENSG00000139567
LRG display in Ensembl gene LRG_543
NCBI gene (formerly Entrezgene) 94
GeneCards 175
HGNC Symbol HGNC:175
MIM gene 601284
MIM morbid 600376
UniProtKB Gene Name P37023
WikiGene 94